Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific nTPM"	"RNA single cell type specificity"	"RNA single cell type distribution"	"RNA single cell type specificity score"	"RNA single cell type specific nTPM"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific nTPM"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific nTPM"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific nTPM"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific nTPM"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific nTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific nTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"CCD Protein"	"CCD Transcript"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Blood expression cluster"	"Tissue expression cluster"	"Cell line expression cluster"	"Single cell expression cluster"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [nTPM]"	"Tissue RNA - adrenal gland [nTPM]"	"Tissue RNA - amygdala [nTPM]"	"Tissue RNA - appendix [nTPM]"	"Tissue RNA - basal ganglia [nTPM]"	"Tissue RNA - bone marrow [nTPM]"	"Tissue RNA - breast [nTPM]"	"Tissue RNA - cerebellum [nTPM]"	"Tissue RNA - cerebral cortex [nTPM]"	"Tissue RNA - cervix [nTPM]"	"Tissue RNA - choroid plexus [nTPM]"	"Tissue RNA - colon [nTPM]"	"Tissue RNA - duodenum [nTPM]"	"Tissue RNA - endometrium 1 [nTPM]"	"Tissue RNA - epididymis [nTPM]"	"Tissue RNA - esophagus [nTPM]"	"Tissue RNA - fallopian tube [nTPM]"	"Tissue RNA - gallbladder [nTPM]"	"Tissue RNA - heart muscle [nTPM]"	"Tissue RNA - hippocampal formation [nTPM]"	"Tissue RNA - hypothalamus [nTPM]"	"Tissue RNA - kidney [nTPM]"	"Tissue RNA - liver [nTPM]"	"Tissue RNA - lung [nTPM]"	"Tissue RNA - lymph node [nTPM]"	"Tissue RNA - medulla oblongata [nTPM]"	"Tissue RNA - midbrain [nTPM]"	"Tissue RNA - ovary [nTPM]"	"Tissue RNA - pancreas [nTPM]"	"Tissue RNA - parathyroid gland [nTPM]"	"Tissue RNA - pituitary gland [nTPM]"	"Tissue RNA - placenta [nTPM]"	"Tissue RNA - pons [nTPM]"	"Tissue RNA - prostate [nTPM]"	"Tissue RNA - rectum [nTPM]"	"Tissue RNA - retina [nTPM]"	"Tissue RNA - salivary gland [nTPM]"	"Tissue RNA - seminal vesicle [nTPM]"	"Tissue RNA - skeletal muscle [nTPM]"	"Tissue RNA - skin 1 [nTPM]"	"Tissue RNA - small intestine [nTPM]"	"Tissue RNA - smooth muscle [nTPM]"	"Tissue RNA - spinal cord [nTPM]"	"Tissue RNA - spleen [nTPM]"	"Tissue RNA - stomach 1 [nTPM]"	"Tissue RNA - testis [nTPM]"	"Tissue RNA - thalamus [nTPM]"	"Tissue RNA - thymus [nTPM]"	"Tissue RNA - thyroid gland [nTPM]"	"Tissue RNA - tongue [nTPM]"	"Tissue RNA - tonsil [nTPM]"	"Tissue RNA - urinary bladder [nTPM]"	"Tissue RNA - vagina [nTPM]"	"Tissue RNA - white matter [nTPM]"	"Cell RNA - A-431 [nTPM]"	"Cell RNA - A549 [nTPM]"	"Cell RNA - AF22 [nTPM]"	"Cell RNA - AN3-CA [nTPM]"	"Cell RNA - ASC diff [nTPM]"	"Cell RNA - ASC TERT1 [nTPM]"	"Cell RNA - BEWO [nTPM]"	"Cell RNA - BJ [nTPM]"	"Cell RNA - BJ hTERT+ [nTPM]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [nTPM]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [nTPM]"	"Cell RNA - CACO-2 [nTPM]"	"Cell RNA - CAPAN-2 [nTPM]"	"Cell RNA - Daudi [nTPM]"	"Cell RNA - EFO-21 [nTPM]"	"Cell RNA - fHDF/TERT166 [nTPM]"	"Cell RNA - GAMG [nTPM]"	"Cell RNA - HaCaT [nTPM]"	"Cell RNA - HAP1 [nTPM]"	"Cell RNA - HBEC3-KT [nTPM]"	"Cell RNA - HBF TERT88 [nTPM]"	"Cell RNA - HDLM-2 [nTPM]"	"Cell RNA - HEK 293 [nTPM]"	"Cell RNA - HEL [nTPM]"	"Cell RNA - HeLa [nTPM]"	"Cell RNA - Hep G2 [nTPM]"	"Cell RNA - HHSteC [nTPM]"	"Cell RNA - HL-60 [nTPM]"	"Cell RNA - HMC-1 [nTPM]"	"Cell RNA - HSkMC [nTPM]"	"Cell RNA - hTCEpi [nTPM]"	"Cell RNA - hTEC/SVTERT24-B [nTPM]"	"Cell RNA - hTERT-HME1 [nTPM]"	"Cell RNA - hTERT-RPE1 [nTPM]"	"Cell RNA - HUVEC TERT2 [nTPM]"	"Cell RNA - JURKAT [nTPM]"	"Cell RNA - K-562 [nTPM]"	"Cell RNA - Karpas-707 [nTPM]"	"Cell RNA - LHCN-M2 [nTPM]"	"Cell RNA - MCF7 [nTPM]"	"Cell RNA - MOLT-4 [nTPM]"	"Cell RNA - NB-4 [nTPM]"	"Cell RNA - NTERA-2 [nTPM]"	"Cell RNA - OE19 [nTPM]"	"Cell RNA - PC-3 [nTPM]"	"Cell RNA - REH [nTPM]"	"Cell RNA - RH-30 [nTPM]"	"Cell RNA - RPMI-8226 [nTPM]"	"Cell RNA - RPTEC TERT1 [nTPM]"	"Cell RNA - RT4 [nTPM]"	"Cell RNA - SCLC-21H [nTPM]"	"Cell RNA - SH-SY5Y [nTPM]"	"Cell RNA - SiHa [nTPM]"	"Cell RNA - SK-BR-3 [nTPM]"	"Cell RNA - SK-MEL-30 [nTPM]"	"Cell RNA - SuSa [nTPM]"	"Cell RNA - T-47d [nTPM]"	"Cell RNA - THP-1 [nTPM]"	"Cell RNA - TIME [nTPM]"	"Cell RNA - U-138 MG [nTPM]"	"Cell RNA - U-2 OS [nTPM]"	"Cell RNA - U-2197 [nTPM]"	"Cell RNA - U-251 MG [nTPM]"	"Cell RNA - U-266/70 [nTPM]"	"Cell RNA - U-266/84 [nTPM]"	"Cell RNA - U-698 [nTPM]"	"Cell RNA - U-87 MG [nTPM]"	"Cell RNA - U-937 [nTPM]"	"Cell RNA - WM-115 [nTPM]"	"Blood RNA - basophil [nTPM]"	"Blood RNA - classical monocyte [nTPM]"	"Blood RNA - eosinophil [nTPM]"	"Blood RNA - gdT-cell [nTPM]"	"Blood RNA - intermediate monocyte [nTPM]"	"Blood RNA - MAIT T-cell [nTPM]"	"Blood RNA - memory B-cell [nTPM]"	"Blood RNA - memory CD4 T-cell [nTPM]"	"Blood RNA - memory CD8 T-cell [nTPM]"	"Blood RNA - myeloid DC [nTPM]"	"Blood RNA - naive B-cell [nTPM]"	"Blood RNA - naive CD4 T-cell [nTPM]"	"Blood RNA - naive CD8 T-cell [nTPM]"	"Blood RNA - neutrophil [nTPM]"	"Blood RNA - NK-cell [nTPM]"	"Blood RNA - non-classical monocyte [nTPM]"	"Blood RNA - plasmacytoid DC [nTPM]"	"Blood RNA - T-reg [nTPM]"	"Blood RNA - total PBMC [nTPM]"	"Brain RNA - amygdala [nTPM]"	"Brain RNA - basal ganglia [nTPM]"	"Brain RNA - cerebellum [nTPM]"	"Brain RNA - cerebral cortex [nTPM]"	"Brain RNA - hippocampal formation [nTPM]"	"Brain RNA - hypothalamus [nTPM]"	"Brain RNA - medulla oblongata [nTPM]"	"Brain RNA - midbrain [nTPM]"	"Brain RNA - pons [nTPM]"	"Brain RNA - spinal cord [nTPM]"	"Brain RNA - thalamus [nTPM]"	"Brain RNA - white matter [nTPM]"	"Single Cell Type RNA - Adipocytes [nTPM]"	"Single Cell Type RNA - Alveolar cells type 1 [nTPM]"	"Single Cell Type RNA - Alveolar cells type 2 [nTPM]"	"Single Cell Type RNA - Astrocytes [nTPM]"	"Single Cell Type RNA - B-cells [nTPM]"	"Single Cell Type RNA - Basal keratinocytes [nTPM]"	"Single Cell Type RNA - Basal prostatic cells [nTPM]"	"Single Cell Type RNA - Basal respiratory cells [nTPM]"	"Single Cell Type RNA - Basal squamous epithelial cells [nTPM]"	"Single Cell Type RNA - Bipolar cells [nTPM]"	"Single Cell Type RNA - Breast glandular cells [nTPM]"	"Single Cell Type RNA - Breast myoepithelial cells [nTPM]"	"Single Cell Type RNA - Cardiomyocytes [nTPM]"	"Single Cell Type RNA - Cholangiocytes [nTPM]"	"Single Cell Type RNA - Club cells [nTPM]"	"Single Cell Type RNA - Collecting duct cells [nTPM]"	"Single Cell Type RNA - Cone photoreceptor cells [nTPM]"	"Single Cell Type RNA - Cytotrophoblasts [nTPM]"	"Single Cell Type RNA - dendritic cells [nTPM]"	"Single Cell Type RNA - Distal enterocytes [nTPM]"	"Single Cell Type RNA - Distal tubular cells [nTPM]"	"Single Cell Type RNA - Ductal cells [nTPM]"	"Single Cell Type RNA - Early spermatids [nTPM]"	"Single Cell Type RNA - Endometrial ciliated cells [nTPM]"	"Single Cell Type RNA - Endometrial stromal cells [nTPM]"	"Single Cell Type RNA - Endothelial cells [nTPM]"	"Single Cell Type RNA - Enteroendocrine cells [nTPM]"	"Single Cell Type RNA - Erythroid cells [nTPM]"	"Single Cell Type RNA - Excitatory neurons [nTPM]"	"Single Cell Type RNA - Exocrine glandular cells [nTPM]"	"Single Cell Type RNA - Extravillous trophoblasts [nTPM]"	"Single Cell Type RNA - Fibroblasts [nTPM]"	"Single Cell Type RNA - Gastric mucus-secreting cells [nTPM]"	"Single Cell Type RNA - Glandular and luminal cells [nTPM]"	"Single Cell Type RNA - granulocytes [nTPM]"	"Single Cell Type RNA - Granulosa cells [nTPM]"	"Single Cell Type RNA - Hepatic stellate cells [nTPM]"	"Single Cell Type RNA - Hepatocytes [nTPM]"	"Single Cell Type RNA - Hofbauer cells [nTPM]"	"Single Cell Type RNA - Horizontal cells [nTPM]"	"Single Cell Type RNA - Inhibitory neurons [nTPM]"	"Single Cell Type RNA - Intestinal goblet cells [nTPM]"	"Single Cell Type RNA - Ionocytes [nTPM]"	"Single Cell Type RNA - Kupffer cells [nTPM]"	"Single Cell Type RNA - Langerhans cells [nTPM]"	"Single Cell Type RNA - Late spermatids [nTPM]"	"Single Cell Type RNA - Leydig cells [nTPM]"	"Single Cell Type RNA - Macrophages [nTPM]"	"Single Cell Type RNA - Melanocytes [nTPM]"	"Single Cell Type RNA - Microglial cells [nTPM]"	"Single Cell Type RNA - monocytes [nTPM]"	"Single Cell Type RNA - Muller glia cells [nTPM]"	"Single Cell Type RNA - NK-cells [nTPM]"	"Single Cell Type RNA - Oligodendrocyte precursor cells [nTPM]"	"Single Cell Type RNA - Oligodendrocytes [nTPM]"	"Single Cell Type RNA - Pancreatic endocrine cells [nTPM]"	"Single Cell Type RNA - Paneth cells [nTPM]"	"Single Cell Type RNA - Peritubular cells [nTPM]"	"Single Cell Type RNA - Plasma cells [nTPM]"	"Single Cell Type RNA - Prostatic glandular cells [nTPM]"	"Single Cell Type RNA - Proximal enterocytes [nTPM]"	"Single Cell Type RNA - Proximal tubular cells [nTPM]"	"Single Cell Type RNA - Respiratory ciliated cells [nTPM]"	"Single Cell Type RNA - Rod photoreceptor cells [nTPM]"	"Single Cell Type RNA - Sertoli cells [nTPM]"	"Single Cell Type RNA - Skeletal myocytes [nTPM]"	"Single Cell Type RNA - Smooth muscle cells [nTPM]"	"Single Cell Type RNA - Spermatocytes [nTPM]"	"Single Cell Type RNA - Spermatogonia [nTPM]"	"Single Cell Type RNA - Squamous epithelial cells [nTPM]"	"Single Cell Type RNA - Suprabasal keratinocytes [nTPM]"	"Single Cell Type RNA - Syncytiotrophoblasts [nTPM]"	"Single Cell Type RNA - T-cells [nTPM]"	"Single Cell Type RNA - Theca cells [nTPM]"	"Single Cell Type RNA - Undifferentiated cells [nTPM]"	"Single Cell Type RNA - Urothelial cells [nTPM]"
ADGRA1	"GPR123, KIAA1828"	ENSG00000197177	"Adhesion G protein-coupled receptor A1"	Q86SQ6	10	133070929-133131675	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"brain: 38.4"	"Group enriched"	"Detected in some"	4	"Excitatory neurons: 25.2;Hepatic stellate cells: 11.7;Inhibitory neurons: 24.6;Oligodendrocyte precursor cells: 29.1"	"Cancer enriched"	"Detected in single"	13	"glioma: 3.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	18	"RH-30: 6.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042773	Approved					NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA042773: AB_10794764"		"unprognostic (8.31e-2)"			"unprognostic (1.88e-1)"	"unprognostic (1.04e-1)"		"unprognostic (2.29e-1)"		"unprognostic (1.54e-1)"	"unprognostic (1.09e-2)"	"unprognostic (7.51e-3)"	"unprognostic (2.48e-2)"	"unprognostic (3.33e-1)"	"unprognostic (1.66e-1)"			0.0	3.8	16.3	0.0	14.2	0.0	0.0	3.3	27.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.1	18.8	15.2	0.4	0.2	0.1	0.0	9.8	18.5	0.0	0.1	0.0	2.8	0.0	10.9	0.0	0.0	0.9	1.8	0.0	0.0	0.0	0.0	0.0	4.2	0.2	0.0	0.7	38.4	0.0	0.0	0.0	0.0	0.0	0.0	15.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	6.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.3	14.2	3.3	27.5	18.8	15.2	9.8	18.5	10.9	4.2	38.4	15.7	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.0	1.5	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	1.5	0.0	2.7	25.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.7	0.0	0.0	0.0	24.6	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	1.0	0.0	0.5	0.0	29.1	2.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.8	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ANK1	"ANK, SPH1"	ENSG00000029534	"Ankyrin 1"	P16157	8	41653220-41896762	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"			"Disease variant, Elliptocytosis, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"skeletal muscle: 993.4;tongue: 629.0"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 164.7;Cone photoreceptor cells: 87.6;Erythroid cells: 250.2;Inhibitory neurons: 176.8;Skeletal myocytes: 51.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"memory B-cell: 9.2;naive B-cell: 7.8;plasmacytoid DC: 3.4"	"Group enriched"	"Detected in many"	4	"B-cells: 9.2;dendritic cells: 3.4"	"Group enriched"	"Detected in many"	4	"HEL: 125.2;K-562: 134.3;RH-30: 160.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004842, HPA056953"	Supported	Supported			"Intracellular and membrane"	NA	NA		4200000	"Cluster 43: B-cells - Humoral immune response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA004842: AB_1844827, HPA056953: AB_2683284"	"unprognostic (1.05e-1)"	"unprognostic (1.30e-1)"	"unprognostic (4.22e-3)"	"unprognostic (2.31e-3)"	"unprognostic (1.76e-7)"	"unprognostic (2.03e-1)"	"unprognostic (2.15e-1)"	"unprognostic (2.52e-1)"	"unprognostic (2.95e-1)"	"unprognostic (3.21e-2)"	"unprognostic (7.90e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.40e-1)"	"unprognostic (3.86e-1)"	"unprognostic (4.65e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.04e-1)"	1.8	1.1	0.4	1.6	2.0	95.2	1.0	34.1	17.3	0.3	0.0	0.5	1.5	0.1	0.1	8.7	0.4	0.8	98.0	0.3	12.5	0.6	0.3	0.7	4.4	26.8	32.6	0.3	0.8	62.1	1.1	2.1	27.1	4.2	0.2	6.3	8.1	0.7	993.4	0.6	0.9	0.3	10.6	2.2	4.4	0.6	8.4	0.7	0.6	629.0	4.0	1.8	0.5	5.4	0.0	16.8	0.5	0.0	0.2	2.9	0.0	4.9	32.8	1.5	0.7	0.1	0.0	7.7	1.5	3.5	0.6	2.8	0.8	0.5	0.7	3.2	0.1	125.2	0.7	0.0	0.1	0.3	0.4	4.2	0.6	0.4	0.0	0.7	0.1	0.0	134.3	2.8	2.1	0.3	0.0	1.6	1.7	0.1	0.1	0.9	160.2	0.8	0.7	0.5	2.2	1.4	0.1	2.3	0.0	5.9	2.0	3.2	0.8	0.5	0.9	27.6	0.2	0.0	0.2	4.7	2.9	0.0	0.0	1.5	0.2	0.0	0.1	0.0	0.4	9.2	0.3	0.4	0.1	7.8	0.0	0.0	0.4	0.1	0.0	3.4	1.0	0.7	0.4	2.0	34.1	17.3	0.3	12.5	26.8	32.6	27.1	10.6	8.4	5.4	5.5	0.0	0.0	1.3	8.3	0.6	1.4	2.2	0.6	15.4	0.3	0.1	164.7	0.0	1.0	0.0	87.6	1.1	0.2	0.1	1.9	0.1	7.0	0.1	0.1	4.6	1.2	250.2	12.9	0.0	0.5	2.9	5.6	0.5	0.0	2.2	0.4	0.1	19.7	3.3	176.8	0.7	2.0	0.8	3.7	6.3	0.3	2.6	0.0	3.7	0.4	1.0	0.0	7.1	2.0	1.1	1.2	0.4	5.7	1.3	0.1	0.3	0.6	5.5	0.0	51.6	5.7	0.2	1.0	0.1	0.0	0.4	1.7	0.1	0.0	1.8
APCDD1L	FLJ90166	ENSG00000198768	"APC down-regulated 1 like"	Q8NCL9	20	58459101-58515399	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"salivary gland: 19.2"	"Cell type enhanced"	"Detected in some"		"Breast glandular cells: 9.1;Breast myoepithelial cells: 7.7;Fibroblasts: 3.6;Oligodendrocyte precursor cells: 6.0;Skeletal myocytes: 8.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 94.5;hTEC/SVTERT24-B: 32.7;HUVEC TERT2: 33.6;TIME: 56.1;U-87 MG: 36.5"					"Not detected"	"Not detected"			HPA067015	Uncertain		Uncertain	Mitochondria		No	No				"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	Mitochondria		"HPA067015: AB_2685764"	"unprognostic (2.61e-1)"	"unprognostic (8.26e-3)"	"unprognostic (4.63e-3)"	"unprognostic (1.35e-5)"	"unprognostic (4.09e-3)"	"unprognostic (9.73e-3)"	"unprognostic (1.31e-3)"	"unprognostic (1.06e-4)"	"unprognostic (7.63e-4)"	"unprognostic (2.14e-2)"	"unprognostic (7.62e-3)"	"unprognostic (2.16e-1)"	"unprognostic (6.55e-13)"	"unprognostic (5.01e-3)"	"unprognostic (3.21e-1)"	"unprognostic (2.24e-2)"	"unprognostic (1.81e-3)"	0.4	0.4	0.2	0.2	0.0	0.0	4.8	0.5	0.1	1.7	0.0	1.0	0.1	1.8	0.0	0.5	0.0	0.7	1.4	0.1	0.0	2.9	0.0	0.0	0.0	0.3	0.0	0.0	0.4	0.0	0.4	0.1	0.0	0.5	0.6	0.0	19.2	1.3	0.6	0.8	0.4	0.6	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	4.4	0.6	0.0	0.0	0.0	0.0	0.0	0.4	3.1	0.0	16.8	0.1	1.9	1.4	0.0	5.6	0.0	0.0	94.5	0.5	1.1	0.0	3.3	3.3	0.0	0.0	0.0	0.0	0.0	11.7	0.0	0.0	2.6	0.0	32.7	0.5	6.8	33.6	0.0	0.0	0.0	1.2	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	56.1	12.6	0.9	0.0	16.5	0.0	0.0	0.0	36.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.1	0.1	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	2.0	0.1	0.0	0.3	0.4	0.0	0.0	9.1	7.7	0.9	0.0	0.0	1.8	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.3	0.0	0.0	0.7	0.0	0.0	3.6	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	1.0	0.0	0.0	0.0	6.0	0.5	0.8	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	8.4	1.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1
BMP5		ENSG00000112175	"Bone morphogenetic protein 5"	P22003	6	55753653-55875590	"Predicted intracellular proteins, Predicted secreted proteins"	"Chondrogenesis, Differentiation, Osteogenesis"	"Cytokine, Developmental protein, Growth factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"placenta: 71.3"	"Group enriched"	"Detected in some"	8	"Cardiomyocytes: 17.7;Fibroblasts: 28.9;Microglial cells: 26.2;Smooth muscle cells: 26.3"	"Cancer enhanced"	"Detected in many"		"lung cancer: 2.8"	"Group enriched"	"Detected in some"	4	"medulla oblongata: 2.3;pons: 2.9"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	11	"AF22: 27.6;U-2 OS: 20.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Secreted - unknown location"	NA	NA				"Cluster 28: Placenta - Pregnancy"	"Cluster 12: NES - Nervous system development"	"Cluster 33: Fibroblasts - ECM organization"				"unprognostic (2.84e-4)"		"unprognostic (9.07e-4)"	"unprognostic (3.50e-1)"	"unprognostic (1.27e-1)"	"unprognostic (6.21e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.39e-3)"		"unprognostic (1.29e-1)"	"unprognostic (1.20e-1)"	"unprognostic (6.76e-2)"	"unprognostic (4.43e-3)"	"unprognostic (3.15e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.30e-1)"	"unprognostic (4.76e-2)"	1.5	1.0	0.1	1.0	0.3	0.2	1.0	0.6	0.5	0.0	2.0	6.2	8.3	0.0	0.0	0.9	0.0	2.3	3.8	0.1	0.0	2.4	3.2	12.9	0.4	2.3	0.3	0.0	1.6	1.1	3.5	71.3	2.9	14.1	7.4	0.0	1.2	0.0	4.4	0.1	9.7	0.3	0.1	0.0	3.3	0.0	0.1	0.2	1.0	12.3	0.2	9.3	0.3	0.0	0.0	0.0	27.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.2	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	2.2	0.0	0.4	0.0	0.0	1.1	0.0	0.0	0.0	0.0	20.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.6	0.5	0.1	0.0	2.3	0.3	2.9	0.1	0.1	0.0	1.8	0.0	3.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.4	1.0	17.7	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	1.2	0.0	2.7	0.4	0.0	0.8	28.9	0.0	0.0	0.0	0.0	2.2	0.0	2.4	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	26.2	0.0	0.0	0.0	0.0	0.1	1.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	2.6	26.3	0.0	0.1	0.3	0.0	1.9	0.6	0.0	0.0	0.1
C21orf58		ENSG00000160298	"Chromosome 21 open reading frame 58"	P58505	21	46300181-46323875	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 26.4;pituitary gland: 20.7"	"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 141.9;Enteroendocrine cells: 69.4;Erythroid cells: 80.2;Respiratory ciliated cells: 164.1;Spermatocytes: 80.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	4	"basophil: 4.4"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 4.4"	"Cell line enhanced"	"Detected in many"		"REH: 62.0"	"Not detected"	"Not detected"							"HPA035110, HPA035111"	Uncertain		Supported	"Nucleoplasm,Nuclear bodies"		NA	Yes			"Cluster 46: Basophils - DNA binding"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 14: REH - Unknown function"	"Cluster 49: Ciliated cells - Cilium organization"	Nucleoplasm	"Nuclear bodies"	"HPA035110: AB_10603683, HPA035111: AB_2674468"	"unprognostic (2.19e-1)"	"unprognostic (6.74e-3)"	"unprognostic (2.51e-1)"	"unprognostic (6.31e-3)"	"unprognostic (1.08e-2)"	"prognostic favorable (7.00e-4)"	"unprognostic (4.74e-3)"	"unprognostic (6.14e-2)"	"prognostic unfavorable (7.48e-4)"	"unprognostic (1.38e-1)"	"prognostic favorable (4.20e-4)"	"unprognostic (1.27e-1)"	"unprognostic (1.01e-10)"	"unprognostic (1.04e-1)"	"unprognostic (1.70e-1)"	"unprognostic (2.51e-1)"	"unprognostic (6.07e-2)"	1.5	1.7	1.9	3.6	2.4	13.1	2.0	2.6	2.3	3.5	3.0	3.2	4.7	2.0	0.7	3.9	26.4	1.0	1.3	1.8	1.9	1.5	1.7	4.8	6.3	2.8	4.6	2.6	2.5	1.2	20.7	2.0	2.0	2.9	2.6	2.5	2.3	1.5	1.7	5.3	4.4	1.3	1.8	3.4	3.5	7.1	2.5	12.8	2.1	0.7	3.8	2.1	2.7	3.2	26.0	11.6	30.2	19.0	2.9	4.0	16.7	15.7	5.7	10.8	10.5	5.4	18.6	18.6	3.8	4.4	12.5	20.3	8.1	6.7	3.2	19.9	17.8	29.9	35.2	3.1	0.7	8.6	16.6	1.7	1.4	7.7	1.9	4.0	6.8	45.4	17.4	48.1	8.9	10.6	42.7	11.6	13.0	7.2	5.7	62.0	13.6	16.6	3.4	4.8	24.7	15.4	11.7	8.3	3.7	6.4	20.5	17.1	4.7	6.6	18.4	6.6	9.6	19.3	9.3	8.8	11.6	37.1	17.4	4.4	0.2	0.6	0.4	0.1	0.2	0.1	0.5	0.6	0.0	0.9	0.9	0.7	0.3	0.3	0.1	1.0	0.8	0.5	1.9	2.4	2.6	2.3	1.8	1.9	2.8	4.6	2.0	1.8	2.5	3.2	2.1	3.2	2.6	4.2	3.1	0.9	1.6	7.0	2.8	19.5	6.2	8.8	3.0	0.0	16.6	1.8	27.1	7.7	9.4	13.9	0.0	1.7	17.3	141.9	7.7	2.3	69.4	80.2	2.7	1.0	5.9	5.9	11.7	4.5	2.5	21.4	2.2	1.5	4.0	5.0	2.5	12.8	14.2	1.6	1.9	32.5	5.3	6.2	0.0	0.0	1.3	5.9	5.2	1.5	4.2	1.2	4.1	2.6	4.8	2.0	3.0	0.7	164.1	28.2	0.0	2.6	5.5	80.8	45.3	8.5	1.4	1.4	3.7	3.9	16.8	0.9
CABP7	MGC57793	ENSG00000100314	"Calcium binding protein 7"	Q86V35	22	29720003-29731833	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"brain: 38.2"	"Cell type enriched"	"Detected in some"	19	"Cardiomyocytes: 28.6"	"Group enriched"	"Detected in some"	4	"glioma: 2.3;ovarian cancer: 1.0;pancreatic cancer: 3.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	12	"HEL: 10.3;SCLC-21H: 9.7;SH-SY5Y: 3.1;U-2 OS: 3.1"	"Group enriched"	"Detected in all"	4	"cerebellum: 74.4;hippocampal formation: 204.8;midbrain: 60.3;pons and medulla: 110.0"	"Region enhanced"	"Detected in all"		"hippocampal formation: 51.0"	HPA016439	Uncertain					NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 36: HEL - Hemostasis"	"Cluster 43: Cardiomyocytes - Nuclear processes"			"HPA016439: AB_2669357"	"unprognostic (1.88e-1)"	"unprognostic (4.75e-2)"	"unprognostic (1.18e-1)"	"unprognostic (5.37e-2)"	"unprognostic (4.55e-1)"	"unprognostic (2.29e-4)"	"unprognostic (2.05e-3)"	"unprognostic (7.96e-2)"	"unprognostic (8.69e-3)"	"unprognostic (3.32e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.22e-1)"	"unprognostic (7.44e-7)"	"unprognostic (1.25e-4)"	"unprognostic (3.60e-2)"	"unprognostic (2.71e-1)"	"unprognostic (4.72e-3)"	0.1	5.6	3.1	0.0	3.0	0.2	0.1	19.8	35.0	0.1	0.6	0.8	0.4	0.1	0.0	0.1	0.1	0.0	0.2	38.2	4.2	0.2	0.3	0.1	0.1	27.7	14.8	0.1	3.1	0.0	0.4	0.0	30.0	0.4	0.0	1.0	0.2	0.0	0.1	0.2	1.5	0.0	22.2	0.4	0.3	0.6	3.9	0.0	0.3	0.0	0.0	0.1	0.1	16.5	0.1	0.5	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.5	10.3	0.3	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.3	0.0	0.0	9.7	3.1	0.0	0.1	0.1	0.0	0.4	0.0	0.0	0.1	3.1	0.1	0.2	0.2	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.2	0.0	0.0	0.1	3.1	3.0	19.8	35.0	38.2	4.2	27.7	14.8	30.0	22.2	3.9	16.5	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.2	0.2	0.1	28.6	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.1	0.8	0.0	0.0	1.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.3	0.1	0.0	1.1	0.5	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	1.3	0.0	1.5	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	1.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.3	0.2	0.0	0.1	0.0
CACNA1B	"CACNL1A5, CACNN, Cav2.2"	ENSG00000148408	"Calcium voltage-gated channel subunit alpha1 B"	Q00975	9	137877782-138124624	"Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted membrane proteins, Voltage-gated ion channels"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Voltage-gated channel"	"Disease variant, Epilepsy, FDA approved drug targets, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 10.2;pituitary gland: 6.8;testis: 5.1"	"Group enriched"	"Detected in some"	8	"Excitatory neurons: 388.8;Inhibitory neurons: 330.9"	"Cancer enhanced"	"Detected in some"		"testis cancer: 2.2"	"Group enriched"	"Detected in many"	8	"amygdala: 5.9;basal ganglia: 7.8;cerebral cortex: 10.2;hippocampal formation: 3.5"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"SCLC-21H: 19.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022919, HPA044347"	Uncertain		Approved	Mitochondria		NA	NA				"Cluster 58: Brain - Synaptic function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Mitochondria		"HPA022919: , HPA044347: AB_10960837"	"unprognostic (1.34e-3)"	"unprognostic (2.70e-2)"	"unprognostic (8.08e-2)"	"unprognostic (2.51e-7)"	"unprognostic (8.10e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.10e-1)"	"unprognostic (2.50e-1)"	"unprognostic (2.36e-2)"	"unprognostic (9.73e-4)"	"unprognostic (5.98e-2)"	"unprognostic (6.63e-6)"	"unprognostic (4.25e-2)"	"unprognostic (4.72e-1)"	"unprognostic (7.77e-3)"	"unprognostic (8.69e-2)"	0.0	2.8	5.9	0.1	7.8	0.0	0.0	0.8	10.2	0.3	0.0	0.4	0.0	0.0	0.6	0.0	3.1	0.4	0.3	3.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.4	0.8	6.8	0.0	0.0	0.5	0.1	3.5	0.0	0.4	0.0	0.2	0.2	0.1	0.0	0.0	0.3	5.1	0.0	1.2	0.2	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.5	3.7	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.9	7.8	0.8	10.2	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	43.4	0.0	0.0	0.1	0.0	0.0	11.7	0.2	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	3.4	0.0	0.2	0.1	0.0	0.0	388.8	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	6.7	330.9	0.0	0.0	0.0	0.0	5.2	0.0	0.0	0.0	17.8	0.6	1.7	0.0	16.1	10.1	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	1.6	0.0	0.0	0.2	8.2	9.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0
CACNA2D2	KIAA0558	ENSG00000007402	"Calcium voltage-gated channel auxiliary subunit alpha2delta 2"	Q9NY47	3	50362613-50504244	"Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Transporters"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Voltage-gated channel"	"Disease variant, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 49.1"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 76.9;Alveolar cells type 2: 182.3;Inhibitory neurons: 36.0"	"Cancer enhanced"	"Detected in many"		"testis cancer: 20.4"	"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	8	"SH-SY5Y: 192.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034771, HPA071829"	Enhanced		Approved	Vesicles		NA	NA		9700000	"Cluster 35: T-regs - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 11: Alveolar cells - Smell perception"	Vesicles		"HPA034771: AB_10603555, HPA071829: AB_2686454"	"unprognostic (2.06e-1)"	"unprognostic (2.37e-1)"	"unprognostic (1.72e-2)"	"prognostic unfavorable (7.62e-5)"	"unprognostic (6.59e-2)"	"unprognostic (6.37e-2)"	"unprognostic (6.91e-2)"	"unprognostic (6.57e-3)"	"unprognostic (4.39e-2)"	"unprognostic (1.17e-1)"	"prognostic favorable (1.21e-4)"	"unprognostic (2.71e-2)"	"unprognostic (1.57e-4)"	"unprognostic (3.03e-1)"	"unprognostic (4.14e-2)"	"unprognostic (3.55e-1)"	"unprognostic (4.22e-2)"	1.0	0.6	4.7	1.3	5.2	1.2	1.2	9.9	6.9	1.4	0.3	1.6	1.2	1.6	0.9	0.6	1.1	0.7	8.4	0.7	13.9	2.3	0.3	49.1	1.2	8.3	8.4	2.1	4.3	2.5	7.1	1.8	14.0	3.0	1.9	8.6	1.3	1.1	1.8	2.6	1.6	1.2	4.8	1.4	4.1	6.5	11.4	1.0	2.2	1.5	0.5	0.5	0.7	2.1	0.0	0.1	3.0	6.6	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.6	0.0	0.6	0.2	24.8	0.0	0.1	0.1	1.8	0.2	0.2	0.1	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.2	0.4	0.0	1.1	0.1	0.2	7.9	0.2	0.5	0.2	0.0	0.7	0.0	0.0	18.6	192.7	0.6	0.4	0.0	5.5	1.5	0.0	0.0	0.1	1.8	0.2	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.7	0.0	0.9	0.7	0.9	0.7	0.0	0.5	1.2	0.7	0.0	0.9	0.0	0.1	1.2	0.4	4.7	5.2	9.9	6.9	0.7	13.9	8.3	8.4	14.0	4.8	11.4	2.1	0.4	76.9	182.3	4.2	0.4	1.5	0.4	0.0	1.8	21.5	2.5	1.7	4.6	0.0	2.5	1.8	20.9	0.0	6.8	0.8	0.0	0.2	0.7	0.1	0.4	0.6	1.2	2.7	7.8	0.0	0.0	1.5	3.1	0.2	20.3	0.3	0.4	0.0	0.1	0.0	36.0	11.0	0.0	0.0	0.4	4.0	0.3	0.4	0.0	1.9	0.1	4.3	15.5	6.0	0.9	0.4	0.3	1.9	2.9	0.7	0.2	0.7	2.2	9.8	13.1	2.4	2.4	2.6	11.2	0.2	0.6	0.3	2.9	3.4	0.6	0.3
CELSR3	"ADGRC3, CDHF11, EGFL1, FMI1, HFMI1, MEGF2"	ENSG00000008300	"Cadherin EGF LAG seven-pass G-type receptor 3"	Q9NYQ7	3	48636463-48662886	"G-protein coupled receptors, Metabolic proteins, Plasma proteins, Predicted membrane proteins"		"Developmental protein, G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 7.3;pituitary gland: 7.3;retina: 3.8;testis: 2.2"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 16.9;Cone photoreceptor cells: 16.7;Enteroendocrine cells: 9.0;Excitatory neurons: 10.1;Horizontal cells: 30.3;Inhibitory neurons: 10.8;Rod photoreceptor cells: 10.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 16.9;HeLa: 16.2;SH-SY5Y: 18.4;SiHa: 16.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA062866	Approved					NA	NA				"Cluster 58: Brain - Synaptic function"	"Cluster 20: HeLa - Mitochondria"	"Cluster 62: Horizontal cells - Visual perception"			"HPA062866: AB_2684886"	"unprognostic (7.80e-2)"	"unprognostic (3.80e-2)"	"unprognostic (4.89e-1)"	"unprognostic (9.12e-4)"	"unprognostic (1.51e-1)"	"unprognostic (1.59e-6)"	"unprognostic (3.61e-6)"	"unprognostic (1.86e-1)"	"unprognostic (1.46e-3)"	"unprognostic (5.07e-2)"	"unprognostic (2.13e-3)"	"unprognostic (2.87e-3)"	"unprognostic (3.26e-3)"	"unprognostic (9.53e-2)"	"unprognostic (1.42e-1)"	"unprognostic (3.86e-2)"	"unprognostic (1.73e-1)"	0.2	1.2	2.4	0.3	2.9	0.6	0.2	7.3	5.6	0.2	0.0	0.3	0.3	0.3	0.3	0.1	0.2	0.1	0.1	2.8	0.7	0.1	0.1	0.2	0.4	0.0	0.0	0.2	0.8	0.2	7.3	0.2	0.0	0.2	0.3	3.8	0.1	0.2	0.1	0.4	0.4	0.2	0.0	0.3	0.6	2.2	0.0	0.1	0.2	0.0	0.2	0.1	0.2	1.1	5.0	3.7	6.0	3.6	0.7	1.1	1.6	0.3	0.7	0.8	1.1	7.0	3.7	1.1	0.9	0.2	3.1	0.6	1.9	0.3	0.4	16.9	1.0	1.7	16.2	2.5	1.1	1.6	2.6	0.5	4.7	0.4	8.5	0.2	0.1	3.5	0.6	5.0	1.2	5.4	0.1	0.1	3.4	1.8	1.6	0.4	0.8	5.2	0.0	3.4	13.5	18.4	16.6	0.3	0.6	0.8	8.1	3.2	0.1	5.9	5.6	7.8	2.9	0.4	9.5	4.4	4.2	1.2	9.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	2.4	2.9	7.3	5.6	2.8	0.7	0.0	0.0	0.0	0.0	0.0	1.1	0.7	0.0	0.5	0.7	0.7	0.4	0.1	0.3	1.2	16.9	1.8	2.0	2.7	0.0	0.1	0.0	16.7	0.2	0.8	1.0	0.0	0.2	3.5	0.7	0.9	0.8	9.0	2.1	10.1	0.0	0.3	0.3	0.5	2.5	1.3	0.5	0.4	0.6	0.2	30.3	10.8	1.9	0.0	0.0	0.3	2.3	0.3	0.3	0.0	0.0	0.1	1.0	0.0	1.5	3.6	0.2	0.1	0.0	0.9	0.2	0.2	0.1	0.2	10.9	0.0	0.3	0.7	5.7	3.9	0.6	0.4	0.1	0.6	0.5	0.5	0.1
CHST8	GALNAC-4-ST1	ENSG00000124302	"Carbohydrate sulfotransferase 8"	Q9H2A9	19	33621953-33773509	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Carbohydrate metabolism"	Transferase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	25	"brain: 30.3;pituitary gland: 63.9"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 15.4;Excitatory neurons: 11.8;Granulosa cells: 7.9;Late spermatids: 56.5;Oligodendrocyte precursor cells: 12.1"	"Group enriched"	"Detected in many"	4	"breast cancer: 4.1;glioma: 4.9;testis cancer: 3.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"RPMI-8226: 24.7;SCLC-21H: 13.5;SH-SY5Y: 23.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA016004	Enhanced				"Intracellular and membrane"	NA	NA				"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 25: Spermatids - Spermatogenesis"			"HPA016004: AB_1846731"	"unprognostic (1.00e-1)"	"unprognostic (6.58e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.45e-2)"	"unprognostic (9.44e-2)"	"unprognostic (2.96e-2)"	"unprognostic (1.15e-2)"	"unprognostic (5.75e-2)"	"unprognostic (8.41e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.83e-2)"	"unprognostic (1.54e-1)"	"unprognostic (6.98e-8)"	"unprognostic (9.37e-3)"	"unprognostic (2.61e-1)"	"unprognostic (3.28e-1)"	"unprognostic (3.87e-2)"	0.7	0.7	7.8	0.3	6.7	0.0	1.8	11.5	10.4	0.9	0.1	0.4	0.0	0.6	0.0	0.3	1.2	0.9	0.4	11.0	11.4	0.1	0.1	0.2	0.4	29.8	7.2	1.0	0.7	0.0	63.9	0.0	30.3	0.7	0.0	0.7	0.2	0.0	0.1	0.3	0.3	0.1	5.4	1.3	0.3	1.4	11.5	0.0	0.6	0.0	0.2	0.3	0.5	8.2	0.0	0.0	0.0	0.3	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.7	0.0	0.0	0.1	0.0	0.0	0.0	1.5	0.0	4.7	0.0	0.0	0.0	1.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	3.6	0.0	0.0	0.0	0.1	24.7	0.0	0.4	13.5	23.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	7.8	6.7	11.5	10.4	11.0	11.4	29.8	7.2	30.3	5.4	11.5	8.2	0.2	0.0	0.0	0.7	0.0	0.8	0.4	0.0	0.0	3.1	3.8	0.6	5.1	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.4	0.3	0.2	0.4	0.0	0.0	11.8	0.0	1.3	0.2	0.0	0.1	0.0	7.9	0.4	0.0	0.1	0.0	0.8	0.0	0.0	0.0	0.0	56.5	0.0	0.0	0.0	0.0	0.0	0.7	0.0	12.1	3.6	0.4	0.0	0.0	0.0	2.0	0.0	0.0	0.0	4.7	0.0	0.3	3.2	0.5	0.7	0.3	0.1	0.0	0.0	0.0	0.0	1.1
CNTN5	"hNB-2, NB-2"	ENSG00000149972	"Contactin 5"	O94779	11	99020949-100358885	"Plasma proteins, Predicted intracellular proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 4.7;placenta: 2.6;salivary gland: 2.0;thyroid gland: 2.0"	"Group enriched"	"Detected in some"	14	"Excitatory neurons: 968.9;Inhibitory neurons: 2295.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA039492, HPA041223"	Approved				"Intracellular and membrane"	NA	NA		480000		"Cluster 65: Brain - Ion transport"		"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA039492: AB_10795108, HPA041223: AB_10794549"	"unprognostic (2.09e-2)"	"unprognostic (3.40e-1)"		"unprognostic (8.99e-3)"	"unprognostic (4.20e-2)"	"unprognostic (6.51e-5)"	"unprognostic (3.85e-2)"	"unprognostic (9.25e-2)"		"unprognostic (6.13e-2)"	"unprognostic (3.02e-2)"	"unprognostic (8.72e-2)"	"unprognostic (5.48e-3)"	"unprognostic (1.81e-2)"	"unprognostic (1.76e-1)"	"unprognostic (5.25e-2)"	"unprognostic (1.25e-1)"	0.0	0.0	1.3	0.0	1.4	0.0	0.0	0.0	4.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	1.1	0.0	0.0	4.7	1.1	0.3	0.0	0.1	0.0	0.0	1.3	0.0	0.2	0.2	0.5	2.6	0.5	0.0	0.0	0.7	2.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.9	0.0	2.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.2	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	1.4	0.0	4.1	4.7	1.1	0.0	1.3	0.5	0.0	2.9	0.1	0.0	0.0	0.0	23.5	0.0	0.0	0.0	0.1	0.0	6.6	0.0	0.0	0.7	0.0	1.4	0.0	0.0	0.4	0.0	0.0	0.0	0.0	3.5	3.5	0.1	0.0	0.0	0.0	968.9	0.0	0.2	1.1	0.0	0.4	0.0	0.0	1.1	0.0	0.2	0.0	2295.2	0.0	2.0	0.0	0.0	0.4	0.9	0.0	0.0	42.2	0.0	0.1	0.0	112.1	23.2	0.1	0.0	1.9	0.0	0.0	0.0	0.2	12.5	0.7	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.1	0.0	0.2	0.0	0.0
DDX25	GRTH	ENSG00000109832	"DEAD-box helicase 25"	Q9UHL0	11	125903348-125943702	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Differentiation, mRNA transport, Spermatogenesis, Translation regulation, Transport"	"Developmental protein, Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"testis: 91.4"	"Group enriched"	"Detected in some"	4	"Early spermatids: 332.1;Spermatocytes: 266.3"	"Cancer enhanced"	"Detected in some"		"glioma: 1.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"JURKAT: 16.1;NTERA-2: 10.8;SCLC-21H: 8.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020137	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA020137: AB_1847552"	"unprognostic (5.78e-3)"	"unprognostic (9.75e-3)"	"unprognostic (7.93e-2)"	"unprognostic (5.09e-3)"	"unprognostic (1.11e-2)"	"unprognostic (1.78e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.91e-3)"	"unprognostic (6.24e-5)"	"unprognostic (2.57e-1)"	"unprognostic (2.44e-3)"	"unprognostic (3.89e-1)"	"unprognostic (3.44e-3)"	"unprognostic (1.44e-1)"	"unprognostic (1.76e-1)"	"unprognostic (9.72e-2)"	"unprognostic (1.69e-1)"	0.4	2.7	15.0	0.1	16.1	0.3	0.3	12.4	17.0	0.3	4.0	0.4	0.4	0.3	0.2	0.1	0.6	0.1	0.0	14.3	16.7	2.6	0.3	0.2	0.1	8.7	10.4	0.6	1.4	1.7	14.9	0.2	10.6	0.2	0.1	21.8	0.2	0.4	0.1	1.1	0.1	0.0	7.6	0.3	0.4	91.4	15.0	0.6	4.7	0.1	0.1	0.0	0.2	13.5	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.2	0.1	1.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	16.1	0.0	0.2	0.0	0.5	1.7	0.0	10.8	0.5	0.0	0.4	0.0	0.0	0.0	0.1	8.7	1.9	0.1	0.0	1.7	1.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.6	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.4	0.2	0.0	0.1	0.0	0.0	15.0	16.1	12.4	17.0	14.3	16.7	8.7	10.4	10.6	7.6	15.0	13.5	0.2	0.0	0.5	16.0	0.5	0.1	0.8	0.0	2.2	18.0	0.1	0.8	1.1	0.0	0.0	0.0	16.7	0.1	0.0	0.0	3.9	0.3	332.1	0.2	0.0	1.0	0.0	0.0	18.0	0.2	0.2	0.4	0.0	0.1	0.0	2.3	0.4	0.5	0.1	16.8	23.1	0.0	0.0	0.0	0.3	66.0	3.7	0.4	0.0	1.9	0.0	20.2	0.0	15.6	3.1	0.1	0.0	4.9	0.0	0.5	0.0	2.7	0.0	16.6	0.0	0.2	0.3	266.3	28.6	0.4	0.0	0.0	0.1	4.0	0.0	0.2
DGKB	"DAGK2, DGK, DGK-BETA, KIAA0718"	ENSG00000136267	"Diacylglycerol kinase beta"	Q9Y6T7	7	14145049-14974777	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"brain: 32.3"	"Group enriched"	"Detected in some"	8	"Excitatory neurons: 937.7;Inhibitory neurons: 576.6;Oligodendrocyte precursor cells: 254.3"	"Cancer enriched"	"Detected in single"	11	"glioma: 1.7"	"Group enriched"	"Detected in many"	7	"basal ganglia: 32.3;cerebral cortex: 14.4;hippocampal formation: 9.2;hypothalamus: 11.9"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 1.2;fHDF/TERT166: 2.6;SCLC-21H: 1.3;U-266/70: 3.3"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"basal ganglia: 192.8"	HPA020321		Supported				NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA020321: "	"unprognostic (9.89e-2)"	"unprognostic (9.72e-5)"	"unprognostic (1.45e-1)"	"unprognostic (2.88e-3)"	"unprognostic (4.32e-2)"	"unprognostic (3.37e-1)"	"unprognostic (7.34e-2)"	"unprognostic (5.91e-2)"	"unprognostic (6.19e-2)"	"unprognostic (8.87e-2)"	"unprognostic (2.72e-2)"	"unprognostic (1.18e-1)"	"unprognostic (5.98e-2)"	"unprognostic (2.37e-3)"	"unprognostic (6.13e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.11e-4)"	0.2	2.6	2.5	0.2	32.3	0.0	0.1	0.0	14.4	2.3	0.0	1.4	0.0	3.3	0.0	0.5	1.6	0.3	0.4	9.2	11.9	1.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.2	0.5	2.0	0.0	0.1	0.3	0.0	0.5	1.4	0.0	0.0	0.6	0.1	0.9	0.1	0.1	1.4	0.0	0.5	0.3	0.0	0.0	0.0	1.2	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	2.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.3	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	32.3	0.0	14.4	9.2	11.9	0.0	0.0	0.0	0.0	0.9	0.0	0.4	0.0	0.0	70.5	0.0	0.1	0.3	0.0	0.0	26.4	0.0	0.0	1.6	0.0	1.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.6	0.2	5.3	0.7	0.0	0.0	937.7	0.0	0.0	0.5	0.0	0.1	0.0	0.1	0.0	0.5	0.1	0.0	576.6	0.0	0.0	0.0	0.5	1.9	1.2	0.1	1.8	43.1	0.0	0.1	0.0	254.3	17.3	0.0	0.0	0.0	0.0	0.2	0.0	2.0	0.0	1.6	6.6	0.5	4.9	0.2	0.5	0.1	0.4	0.0	0.1	0.1	0.0	0.3
FAM135B	C8ORFK32	ENSG00000147724	"Family with sequence similarity 135 member B"	Q49AJ0	8	138130023-138497261	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 10.7;retina: 9.1;testis: 3.8"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 64.3;Early spermatids: 157.1;Excitatory neurons: 229.3;Inhibitory neurons: 267.0"	"Cancer enhanced"	"Detected in single"		"glioma: 0.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	11	"RH-30: 8.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA023911, HPA023950, HPA024815"	Uncertain		Approved	"Nucleoplasm,Nuclear membrane"		NA	NA				"Cluster 58: Brain - Synaptic function"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nuclear membrane"	Nucleoplasm	"HPA023911: AB_1845791, HPA023950: AB_1845792, HPA024815: AB_10601376"	"unprognostic (3.78e-1)"	"unprognostic (4.80e-1)"	"unprognostic (1.71e-2)"	"unprognostic (6.64e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.42e-1)"	"unprognostic (8.26e-2)"	"unprognostic (8.36e-3)"	"unprognostic (4.54e-2)"	"unprognostic (6.85e-4)"	"unprognostic (9.92e-3)"	"unprognostic (9.82e-3)"	"unprognostic (4.47e-1)"	"unprognostic (2.70e-2)"	"unprognostic (3.51e-2)"	"unprognostic (1.30e-1)"	0.1	2.6	4.8	0.1	4.8	0.0	0.0	6.1	10.7	0.0	0.0	0.8	0.3	0.0	0.1	0.0	0.0	0.0	0.1	6.8	1.1	0.3	0.0	0.0	0.0	5.0	3.0	0.0	0.4	0.0	1.3	0.0	5.1	0.2	0.6	9.1	0.0	0.2	0.0	0.0	0.3	0.0	1.8	0.0	0.6	3.8	3.4	0.1	0.0	0.3	0.0	0.4	0.1	5.7	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	8.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	4.8	6.1	10.7	6.8	1.1	5.0	3.0	5.1	1.8	3.4	5.7	0.0	0.0	0.0	64.3	0.0	0.0	0.0	0.0	0.0	32.2	0.0	0.0	1.4	0.0	0.0	0.0	29.2	0.0	0.0	0.0	0.0	0.0	157.1	0.0	0.0	0.1	1.8	0.0	229.3	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	267.0	0.0	0.0	0.0	0.4	32.7	1.5	0.1	0.0	8.4	0.0	2.9	0.0	34.2	17.5	0.0	0.0	1.2	0.0	0.0	0.0	0.1	0.0	2.0	0.0	0.3	0.1	1.1	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
FRRS1L	"C9orf4, CG-6"	ENSG00000260230	"Ferric chelate reductase 1 like"	Q9P0K9	9	109130293-109167249	"Disease related genes, Human disease related genes, Predicted membrane proteins"			"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 18.6;ovary: 11.0"	"Group enriched"	"Detected in many"	4	"Bipolar cells: 59.1;Excitatory neurons: 91.6;Horizontal cells: 97.6;Inhibitory neurons: 81.3;Oligodendrocyte precursor cells: 27.6"	"Cancer enhanced"	"Detected in some"		"glioma: 1.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 1.6;SH-SY5Y: 3.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071086	Enhanced					NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 62: Horizontal cells - Visual perception"			"HPA071086: AB_2686342"	"unprognostic (7.44e-2)"	"unprognostic (1.90e-1)"	"unprognostic (2.96e-2)"	"unprognostic (2.21e-1)"	"unprognostic (9.01e-2)"	"unprognostic (3.10e-1)"	"unprognostic (8.12e-2)"	"unprognostic (1.84e-1)"	"unprognostic (9.94e-2)"	"unprognostic (1.51e-1)"	"unprognostic (9.21e-4)"	"unprognostic (7.35e-3)"	"unprognostic (7.02e-2)"	"unprognostic (5.78e-3)"	"unprognostic (5.89e-2)"	"unprognostic (2.85e-1)"	"unprognostic (5.38e-3)"	0.1	7.8	15.1	0.3	16.6	0.3	0.3	9.2	17.3	1.3	0.0	0.7	0.4	1.5	2.8	1.9	1.4	1.0	1.0	18.6	15.4	0.1	0.1	0.2	0.2	2.5	6.3	11.0	0.6	3.0	7.2	0.0	6.2	3.1	0.3	7.8	0.2	1.7	0.1	0.2	0.5	1.5	6.9	0.2	0.8	0.7	15.4	0.0	0.2	0.1	0.1	0.1	0.2	7.1	0.0	0.2	1.6	0.0	0.2	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.7	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.6	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.4	0.1	0.2	0.1	0.0	0.0	15.1	16.6	9.2	17.3	18.6	15.4	2.5	6.3	6.2	6.9	15.4	7.1	0.1	3.2	0.6	1.3	0.1	0.4	1.5	0.0	0.6	59.1	0.7	0.4	5.0	0.0	0.6	0.0	2.1	0.4	1.5	1.6	0.0	0.0	7.9	3.2	1.6	0.8	1.2	0.0	91.6	0.0	0.2	4.3	0.0	1.8	1.3	16.3	0.4	0.1	0.1	97.6	81.3	0.8	0.0	0.6	1.2	4.6	13.1	0.5	1.8	4.7	0.2	16.6	0.0	27.6	5.9	0.1	0.4	17.0	0.0	1.1	4.1	0.1	0.0	7.0	0.0	1.6	1.5	0.3	1.2	0.0	0.6	0.3	0.3	10.8	1.3	0.8
GALNT8	GALNAC-T8	ENSG00000130035	"Polypeptide N-acetylgalactosaminyltransferase 8"	Q9NY28	12	4720400-4851927	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"intestine: 31.3;testis: 13.5"	"Group enriched"	"Detected in some"	6	"Early spermatids: 95.2;Intestinal goblet cells: 47.0;Late spermatids: 150.2"	"Group enriched"	"Detected in some"	4	"colorectal cancer: 1.2;glioma: 1.8;pancreatic cancer: 0.8;testis cancer: 2.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"Karpas-707: 23.4;U-266/84: 7.6"					"Not detected"	"Not detected"			"HPA012638, HPA073461"	Supported		Approved	"Golgi apparatus,Vesicles"	"Intracellular and membrane"	NA	No			"Cluster 22: NK-cells - Unknown function"	"Cluster 45: Intestine - Brush border"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 31: Spermatids - Spermatogenesis"	"Golgi apparatus, Vesicles"		"HPA012638: AB_2294503, HPA073461: AB_2686604"	"unprognostic (2.36e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.13e-2)"	"unprognostic (1.75e-2)"	"unprognostic (6.24e-2)"	"unprognostic (2.87e-1)"	"unprognostic (2.59e-2)"	"unprognostic (3.79e-1)"	"unprognostic (2.72e-1)"	"unprognostic (5.76e-2)"	"unprognostic (8.06e-5)"	"unprognostic (1.16e-2)"	"unprognostic (6.67e-5)"	"unprognostic (5.18e-2)"	"unprognostic (2.59e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.33e-2)"	0.4	0.6	3.2	1.8	3.3	0.0	0.6	2.7	5.1	0.5	2.0	14.0	5.7	0.3	0.1	0.1	0.6	0.0	2.5	3.2	2.8	0.4	0.2	0.3	0.2	3.4	3.2	0.7	0.2	0.0	2.8	0.1	3.3	0.4	31.3	0.2	0.4	0.3	0.1	0.2	12.6	0.8	2.9	0.5	0.5	13.5	3.3	0.0	0.2	0.0	0.0	0.4	0.3	4.1	0.0	0.0	0.5	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	23.4	0.0	0.0	0.0	0.1	3.1	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	7.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.0	3.2	3.3	2.7	5.1	3.2	2.8	3.4	3.2	3.3	2.9	3.3	4.1	0.1	6.4	0.5	1.3	0.5	0.0	0.0	0.1	0.6	2.1	0.1	2.3	4.5	0.0	0.0	0.0	0.0	0.0	1.5	1.8	0.0	0.0	95.2	0.5	0.1	0.5	6.6	0.0	1.1	0.4	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	4.7	47.0	0.0	0.0	0.0	150.2	1.5	0.1	0.0	3.7	0.2	0.5	0.0	15.1	7.4	0.2	0.6	2.6	0.0	0.1	1.0	1.0	0.0	0.6	6.6	0.7	0.1	12.3	8.3	0.0	0.0	0.0	0.8	0.3	2.2	0.0
GLRA3		ENSG00000145451	"Glycine receptor alpha 3"	O75311	4	174636920-174829247	"FDA approved drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Chloride channel, Ion channel, Ligand-gated ion channel, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 10.5"	"Cell type enhanced"	"Detected in some"		"Breast glandular cells: 25.3;Early spermatids: 24.7;Excitatory neurons: 52.4;Inhibitory neurons: 11.2;Late spermatids: 22.8"	"Cancer enhanced"	"Detected in single"		"breast cancer: 1.2"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"Karpas-707: 1.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"									NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 65: Brain - Ion transport"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"				"unprognostic (2.75e-3)"	"unprognostic (3.14e-1)"	"unprognostic (1.78e-2)"		"unprognostic (1.36e-1)"	"unprognostic (9.02e-2)"		"unprognostic (3.82e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.12e-2)"	"unprognostic (4.26e-2)"	"unprognostic (1.64e-5)"	"unprognostic (4.61e-4)"	"unprognostic (2.24e-1)"		"unprognostic (1.15e-2)"	0.0	0.8	4.2	0.0	3.4	0.0	2.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	4.5	0.0	0.0	0.0	0.2	0.8	3.6	0.0	0.4	0.0	0.6	0.0	0.6	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.1	0.9	0.0	0.0	0.5	10.5	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	4.2	3.4	0.0	3.0	2.6	4.5	0.8	3.6	0.6	0.9	10.5	0.0	0.0	0.0	0.6	1.3	1.6	0.0	1.3	0.0	0.0	5.0	25.3	0.3	2.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.7	0.0	0.1	0.4	0.0	0.0	52.4	0.0	0.0	1.3	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	11.2	0.0	0.0	0.0	0.0	22.8	0.0	0.1	0.0	2.8	0.0	0.2	0.0	1.0	1.0	0.2	0.0	0.0	0.0	1.1	0.0	0.1	0.0	0.6	0.0	1.0	0.3	0.7	1.6	0.1	0.1	0.0	0.3	0.0	0.0	0.4
GNAO1	G-ALPHA-o	ENSG00000087258	"G protein subunit alpha o1"	P09471	16	56191390-56357444	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		Transducer	"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 171.2;retina: 52.4"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 135.8;Bipolar cells: 189.2;Excitatory neurons: 138.7;Inhibitory neurons: 132.2;Oligodendrocyte precursor cells: 87.9;Oligodendrocytes: 368.3"	"Cancer enriched"	"Detected in many"	5	"glioma: 11.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 30.7;BJ hTERT+ SV40 Large T+: 20.0;SCLC-21H: 61.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008387, HPA040878"	Enhanced					NA	NA		510000		"Cluster 65: Brain - Ion transport"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 56: Bipolar cells - Visual perception"			"CAB008387: AB_591430, HPA040878: AB_2677184"	"unprognostic (1.50e-1)"	"unprognostic (1.36e-3)"	"unprognostic (8.12e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.21e-1)"	"unprognostic (3.63e-2)"	"unprognostic (6.87e-2)"	"unprognostic (1.68e-4)"	"unprognostic (3.08e-1)"	"unprognostic (1.74e-1)"	"prognostic favorable (5.93e-4)"	"unprognostic (1.71e-1)"	"unprognostic (6.86e-3)"	"unprognostic (6.28e-2)"	"unprognostic (1.21e-1)"	"unprognostic (6.00e-1)"	"unprognostic (9.70e-5)"	3.0	7.9	100.8	3.4	171.2	0.1	1.1	55.1	121.9	2.1	0.0	34.0	3.1	7.7	3.0	2.9	2.9	2.5	34.1	101.9	87.6	1.1	10.2	0.9	1.1	74.6	89.6	1.7	3.9	1.5	28.5	0.5	77.9	5.1	5.1	52.4	2.3	16.5	2.0	1.4	7.3	10.2	44.6	1.3	11.0	13.8	107.3	1.1	1.9	0.6	1.1	7.9	2.5	110.3	7.3	0.0	0.6	0.1	0.0	0.1	0.9	7.6	30.7	20.0	9.5	0.4	0.0	0.0	0.2	0.0	7.3	0.6	4.9	0.0	13.7	0.2	0.9	0.0	2.0	0.0	0.0	0.0	2.7	0.1	0.2	0.0	0.0	0.0	0.0	6.1	0.0	0.2	0.0	0.8	0.0	0.1	11.1	0.3	0.1	0.1	7.1	0.1	0.0	0.0	61.2	12.2	12.5	0.2	0.7	3.1	0.2	0.0	0.0	0.2	6.8	0.0	3.6	0.8	0.0	0.1	0.3	0.5	1.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	100.8	171.2	55.1	121.9	101.9	87.6	74.6	89.6	77.9	44.6	107.3	110.3	0.6	0.0	0.5	135.8	0.8	0.8	0.3	0.2	0.0	189.2	1.4	0.6	43.3	1.5	0.1	0.0	6.2	0.4	4.9	0.1	0.0	0.0	26.8	0.7	4.4	1.5	23.3	0.8	138.7	0.0	0.2	6.8	1.5	1.2	0.0	0.2	0.7	10.4	0.1	79.1	132.2	1.0	0.0	0.8	2.1	53.6	34.8	1.7	3.6	13.1	0.0	20.5	1.0	87.9	368.3	0.3	0.0	44.4	2.1	0.4	0.1	0.3	0.1	13.1	0.0	8.2	5.6	15.4	8.8	0.3	0.4	0.1	7.2	0.1	0.3	0.2
GNG4		ENSG00000168243	"G protein subunit gamma 4"	P50150	1	235547685-235650754	"Predicted intracellular proteins, RAS pathway related proteins"		Transducer		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 40.9;ovary: 32.1;pituitary gland: 32.0"	"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 24.4;Enteroendocrine cells: 43.0;Inhibitory neurons: 43.3;Intestinal goblet cells: 16.2;Oligodendrocyte precursor cells: 25.1;Prostatic glandular cells: 24.1;Proximal enterocytes: 24.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"basophil: 1.2"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 1.2"	"Cell line enhanced"	"Detected in many"		"NTERA-2: 151.4;SCLC-21H: 158.4;SH-SY5Y: 222.8;U-2197: 67.2"	"Region enriched"	"Detected in all"	6	"olfactory bulb: 469.3"											NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"				"unprognostic (1.50e-3)"	"unprognostic (8.33e-3)"	"unprognostic (7.14e-2)"	"unprognostic (1.56e-2)"	"unprognostic (2.48e-1)"	"unprognostic (4.94e-2)"	"unprognostic (2.22e-2)"	"unprognostic (3.10e-2)"	"unprognostic (3.47e-2)"	"unprognostic (3.49e-1)"	"unprognostic (1.79e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.56e-9)"	"unprognostic (1.22e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.68e-3)"	"unprognostic (5.01e-3)"	1.4	11.3	20.0	1.7	25.6	0.1	0.6	7.9	21.0	4.7	3.1	3.6	2.5	9.5	0.1	14.4	3.3	0.5	0.1	15.4	40.9	1.9	0.3	0.1	5.7	21.3	28.2	32.1	5.1	0.0	32.0	1.7	25.4	22.6	3.0	2.4	2.0	0.7	0.1	0.5	5.3	6.6	18.9	0.1	3.1	1.7	33.6	4.9	0.3	0.0	3.4	1.0	2.4	7.3	37.2	2.0	26.4	0.0	0.0	1.3	2.4	0.1	0.4	3.3	4.5	0.1	1.5	0.0	0.3	11.2	9.0	3.3	28.4	1.2	6.7	19.4	10.2	0.1	0.7	14.4	0.4	0.2	12.1	2.4	0.2	0.4	0.9	0.0	0.0	2.0	0.3	0.1	2.1	0.1	7.6	1.2	151.4	0.1	0.1	0.0	13.8	0.7	0.0	1.1	158.4	222.8	0.9	0.3	3.2	1.7	0.2	5.3	0.0	1.7	5.0	67.2	5.2	3.5	0.2	0.0	4.9	0.1	44.5	1.2	0.1	0.1	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.2	0.1	0.0	0.3	0.2	0.1	0.0	0.1	0.1	20.0	25.6	7.9	21.0	15.4	40.9	21.3	28.2	25.4	18.9	33.6	7.3	0.1	0.0	0.0	2.9	0.2	0.5	2.6	0.3	0.0	2.3	0.2	0.9	0.5	0.0	1.0	0.0	0.0	7.7	2.7	1.6	0.0	0.0	1.1	1.5	24.4	1.4	43.0	0.0	2.3	9.0	10.0	1.7	0.0	0.8	0.0	3.8	0.0	0.0	0.9	1.7	43.3	16.2	4.1	0.0	3.6	1.0	0.3	1.1	0.0	4.7	1.0	0.4	0.0	25.1	0.8	1.6	1.3	0.4	0.1	24.1	24.5	4.9	0.2	1.3	0.0	0.2	1.6	1.8	4.4	0.0	0.0	6.3	1.1	0.3	4.6	1.5
GPR148	PGR6	ENSG00000173302	"G protein-coupled receptor 148"	Q8TDV2	2	130729070-130730336	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA046655, HPA060527"	Uncertain		Supported	"Plasma membrane"		NA	NA							"Plasma membrane"		"HPA046655: , HPA060527: AB_2684307"											"unprognostic (7.16e-4)"				"unprognostic (3.38e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.1	0.0	0.5	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.7	0.0	0.2	0.3	0.1	0.4	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GPR158	KIAA1136	ENSG00000151025	"G protein-coupled receptor 158"	Q5T848	10	25174802-25602229	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"brain: 24.9"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 367.4;Horizontal cells: 144.7;Inhibitory neurons: 301.9;Oligodendrocyte precursor cells: 419.7;Oligodendrocytes: 101.6"	"Cancer enhanced"	"Detected in many"		"glioma: 2.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"HEL: 21.3;T-47d: 5.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA013185	Uncertain					NA	NA				"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 36: HEL - Hemostasis"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA013185: AB_2113957"	"unprognostic (4.43e-2)"	"unprognostic (3.14e-2)"	"unprognostic (7.42e-2)"	"unprognostic (2.66e-5)"	"unprognostic (5.67e-2)"	"unprognostic (9.37e-2)"	"unprognostic (4.73e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.22e-1)"	"unprognostic (4.37e-2)"	"unprognostic (8.09e-3)"	"unprognostic (1.72e-1)"	"unprognostic (2.60e-6)"	"unprognostic (8.36e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.21e-3)"	"unprognostic (3.90e-1)"	0.0	0.7	2.6	0.1	12.7	0.0	0.0	24.9	8.6	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.5	2.4	0.0	0.0	0.0	0.0	8.5	4.7	0.0	0.0	0.2	1.4	0.3	8.8	0.1	0.1	4.5	0.0	0.2	0.0	0.0	0.2	0.0	2.3	0.0	0.1	0.5	7.0	0.0	0.1	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.1	0.0	0.2	0.0	0.0	0.0	0.0	2.6	0.0	21.3	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.2	0.4	0.0	0.0	0.1	0.0	0.5	0.0	0.3	0.2	0.0	0.0	1.2	0.0	0.5	1.1	1.9	0.0	5.6	0.0	0.0	0.0	0.5	0.3	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	12.7	24.9	8.6	3.5	2.4	8.5	4.7	8.8	2.3	7.0	4.3	0.0	0.0	0.0	12.1	0.0	0.0	0.0	0.0	0.0	8.8	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	19.9	0.0	0.1	0.1	0.0	0.0	367.4	0.0	0.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	144.7	301.9	0.0	0.0	0.0	0.0	12.0	0.0	0.1	0.0	10.3	0.0	26.2	0.0	419.7	101.6	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.0	3.8	0.0	0.1	0.1	1.8	1.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0
GRM4	"GPRC1D, mGlu4, MGLUR4"	ENSG00000124493	"Glutamate metabotropic receptor 4"	Q14833	6	34018643-34155622	"G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	93	"brain: 80.3"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 5.3;Early spermatids: 3.7;Enteroendocrine cells: 3.0;Excitatory neurons: 9.5;Inhibitory neurons: 10.8;Spermatogonia: 5.0"	"Cancer enhanced"	"Detected in some"		"testis cancer: 1.7"	"Region enriched"	"Detected in all"	7	"cerebellum: 80.3"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"BEWO: 7.6;SCLC-21H: 18.2"	"Region enhanced"	"Detected in all"		"cerebellum: 79.1"	"Region enriched"	"Detected in many"	5	"cerebellum: 138.8"	CAB022096	Enhanced					NA	NA				"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"CAB022096: "	"unprognostic (1.29e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.03e-1)"	"unprognostic (7.00e-2)"	"unprognostic (4.03e-2)"	"unprognostic (8.36e-2)"	"unprognostic (9.05e-3)"	"unprognostic (3.56e-1)"	"unprognostic (9.45e-2)"	"unprognostic (2.08e-2)"	"unprognostic (6.21e-3)"	"unprognostic (2.44e-1)"	"unprognostic (2.15e-11)"	"unprognostic (5.32e-2)"	"unprognostic (9.16e-2)"	"unprognostic (6.57e-2)"	"unprognostic (3.07e-1)"	0.0	0.2	3.1	0.0	10.7	0.0	0.0	80.3	5.2	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	2.2	1.7	0.0	0.0	0.0	0.0	2.6	3.5	0.1	0.7	0.0	0.5	0.0	5.0	0.1	0.0	0.8	0.0	0.0	0.0	0.1	0.2	0.1	1.1	0.0	0.0	0.8	6.5	0.0	0.0	0.0	0.1	0.0	0.1	2.0	0.0	0.0	0.0	0.0	0.0	0.0	7.6	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	18.2	0.1	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	10.7	80.3	5.2	2.2	1.7	2.6	3.5	5.0	1.1	6.5	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	5.3	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	3.7	0.4	0.1	0.2	3.0	0.0	9.5	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	10.8	1.1	0.0	0.3	0.3	2.4	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.5	0.0	0.1	0.0	0.0	0.3	0.0	0.1	0.1	0.7	0.0	0.0	0.1	0.9	5.0	0.0	0.0	0.1	0.4	0.0	0.3	0.1
JAKMIP1	"FLJ31564, Gababrbp, JAMIP1, MARLIN1"	ENSG00000152969	"Janus kinase and microtubule interacting protein 1"	Q96N16	4	6026199-6200591	"Predicted intracellular proteins, Predicted membrane proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 31.1;pituitary gland: 10.2;retina: 17.0"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 35.6;dendritic cells: 17.6;Excitatory neurons: 82.9;Inhibitory neurons: 53.6;Muller glia cells: 61.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	17	"gdT-cell: 25.3;MAIT T-cell: 11.2;memory CD4 T-cell: 11.2;memory CD8 T-cell: 22.6;naive CD8 T-cell: 10.1;T-reg: 36.7"	"Lineage enriched"	"Detected in many"	33	"T-cells: 36.7"	"Cell line enhanced"	"Detected in some"		"Daudi: 15.8;JURKAT: 14.3;MOLT-4: 45.2;SCLC-21H: 18.6;U-266/70: 26.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044570	Uncertain					NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA044570: AB_2678995"	"unprognostic (4.79e-2)"	"unprognostic (3.46e-3)"	"unprognostic (4.90e-2)"	"unprognostic (1.73e-2)"	"unprognostic (5.34e-2)"	"unprognostic (3.86e-3)"	"unprognostic (6.16e-2)"	"unprognostic (6.69e-3)"	"unprognostic (4.25e-4)"	"unprognostic (7.14e-2)"	"unprognostic (4.57e-3)"	"unprognostic (1.13e-1)"	"unprognostic (3.70e-8)"	"unprognostic (1.85e-2)"	"unprognostic (3.15e-1)"	"unprognostic (4.23e-2)"	"unprognostic (2.96e-3)"	0.3	4.8	21.4	1.0	31.1	1.3	0.1	5.0	30.4	0.2	0.1	1.0	0.2	0.1	0.1	0.3	0.2	0.5	0.1	21.6	22.0	0.2	0.3	0.9	3.0	9.0	13.5	0.5	0.6	0.0	10.2	0.0	12.8	4.2	0.2	17.0	0.7	0.1	0.1	0.1	1.1	0.2	7.1	2.6	0.6	5.2	16.2	0.3	0.7	0.0	0.6	0.7	0.3	20.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.8	0.0	0.0	2.6	0.0	0.0	0.0	0.0	8.7	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.3	0.0	0.0	0.0	0.4	45.2	0.0	3.4	0.0	2.6	2.3	0.0	0.7	0.0	0.0	18.6	6.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.3	4.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	25.3	0.0	11.2	0.3	11.2	22.6	0.0	0.2	0.8	10.1	0.1	1.1	0.0	0.1	36.7	5.4	21.4	31.1	5.0	30.4	21.6	22.0	9.0	13.5	12.8	7.1	16.2	20.3	0.2	0.0	0.0	35.6	0.8	0.0	0.0	0.0	0.0	1.5	0.2	0.1	0.8	0.0	0.0	0.0	2.1	0.0	17.6	0.0	0.0	0.0	1.5	0.1	0.2	0.1	0.0	0.4	82.9	0.0	0.0	0.5	2.6	0.8	0.0	0.2	0.0	0.0	0.1	3.3	53.6	0.0	0.0	1.3	0.5	2.4	0.0	0.5	0.0	7.5	0.3	61.2	12.3	7.1	3.1	0.1	0.0	0.0	2.3	1.3	0.0	0.1	0.0	5.4	0.0	0.0	0.2	0.9	4.6	0.0	0.1	0.0	16.2	0.4	0.0	0.0
KCNA5	"HK2, HPCN1, Kv1.5"	ENSG00000130037	"Potassium voltage-gated channel subfamily A member 5"	P22460	12	5043879-5046788	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"Atrial fibrillation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"choroid plexus: 52.7;heart muscle: 39.8"	"Cell type enriched"	"Detected in some"	4	"Bipolar cells: 143.1"	"Cancer enhanced"	"Detected in some"		"pancreatic cancer: 2.2"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	122	"plasmacytoid DC: 12.2"	"Lineage enriched"	"Detected in single"	122	"dendritic cells: 12.2"	"Cell line enriched"	"Detected in single"	13	"NTERA-2: 4.2"	"Low region specificity"	"Detected in many"							"HPA021516, CAB022562"	Approved					NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 56: Bipolar cells - Visual perception"			"CAB022562: , HPA021516: AB_2670732"	"unprognostic (3.87e-1)"	"unprognostic (9.91e-3)"	"unprognostic (1.94e-1)"	"unprognostic (3.23e-1)"	"unprognostic (2.64e-1)"	"unprognostic (7.06e-3)"	"unprognostic (1.20e-1)"	"unprognostic (4.61e-3)"	"unprognostic (1.34e-1)"	"unprognostic (2.14e-1)"	"unprognostic (2.37e-2)"	"unprognostic (5.08e-3)"	"unprognostic (6.73e-4)"	"unprognostic (1.92e-3)"	"unprognostic (1.90e-1)"	"unprognostic (2.86e-2)"	"unprognostic (3.08e-2)"	2.2	0.5	3.1	0.2	4.6	0.1	1.4	2.2	3.8	0.8	52.7	3.6	0.3	1.5	0.3	4.9	1.8	0.8	39.8	6.0	7.5	1.1	0.2	2.8	0.2	3.7	6.2	2.4	1.3	0.0	7.1	1.9	2.7	0.6	0.5	7.5	0.3	0.9	3.8	0.5	1.2	0.5	4.3	0.5	3.6	0.2	5.4	0.1	1.3	4.8	0.4	3.6	1.1	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.2	0.0	0.0	3.1	4.6	2.2	3.8	6.0	7.5	3.7	6.2	2.7	4.3	5.4	4.7	0.7	0.0	0.0	0.3	1.6	0.9	0.0	0.0	0.0	143.1	0.0	0.0	20.9	0.0	0.0	0.0	2.1	0.1	10.7	0.0	0.0	0.0	0.0	0.0	0.1	2.9	3.5	0.0	0.3	0.0	0.0	3.7	0.0	0.0	0.0	4.2	0.0	0.0	0.3	0.0	1.0	0.0	0.0	0.0	1.4	0.0	0.0	0.3	0.0	3.7	0.1	1.9	0.0	1.5	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	4.0	13.1	3.5	29.0	0.0	0.0	0.0	0.3	0.1	0.1	0.0	0.0	0.1
KIF5C		ENSG00000168280	"Kinesin family member 5C"	O60282	2	148875227-149026759	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	Transport	"Motor protein"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 65.2"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 252.2;Early spermatids: 568.4;Excitatory neurons: 267.2;Inhibitory neurons: 249.1;Late spermatids: 702.5;Oligodendrocytes: 270.7"	"Cancer enhanced"	"Detected in many"		"glioma: 11.7;prostate cancer: 19.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"SCLC-21H: 117.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035210, HPA062272"	Enhanced		Approved	Vesicles		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 34: Spermatids - Unknown function"	Vesicles		"HPA035210: AB_10671931, HPA062272: AB_2732678"	"unprognostic (1.95e-1)"	"unprognostic (2.39e-1)"	"unprognostic (2.54e-1)"	"unprognostic (4.70e-4)"	"unprognostic (1.89e-1)"	"unprognostic (3.79e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.90e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.41e-2)"	"unprognostic (6.61e-3)"	"unprognostic (1.56e-1)"	"unprognostic (6.55e-6)"	"unprognostic (8.34e-3)"	"unprognostic (3.69e-1)"	"unprognostic (3.63e-2)"	"unprognostic (4.46e-2)"	0.5	5.1	41.3	0.6	17.6	0.0	0.5	13.9	65.2	1.4	0.0	1.1	0.3	0.5	3.7	0.1	0.9	0.1	0.6	28.9	13.7	0.2	0.0	0.2	0.3	15.4	9.0	1.6	2.3	0.3	5.5	0.0	24.6	10.4	0.6	7.8	0.2	2.8	0.3	0.3	0.8	0.4	16.3	0.2	0.6	12.1	49.8	0.1	1.3	0.9	0.2	0.6	1.4	32.0	0.0	0.0	17.8	3.6	0.0	0.0	0.0	0.0	0.0	0.8	0.6	0.2	0.0	0.7	0.0	0.2	5.4	0.0	14.1	0.0	1.3	13.7	3.0	0.5	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.4	0.2	0.7	0.0	0.7	0.0	0.1	0.0	0.8	0.0	0.0	22.4	0.0	9.2	0.0	0.1	0.1	0.0	3.6	117.1	27.1	0.2	0.5	0.2	2.8	0.0	0.0	0.0	0.0	3.3	0.0	3.7	3.0	0.4	0.0	8.8	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	41.3	17.6	13.9	65.2	28.9	13.7	15.4	9.0	24.6	16.3	49.8	32.0	1.8	0.0	0.0	33.6	2.4	1.3	6.1	0.1	2.2	252.2	8.0	3.7	14.9	4.3	0.0	18.4	108.4	0.0	0.8	1.1	0.0	0.3	568.4	0.9	1.6	6.1	129.7	0.0	267.2	0.0	0.1	4.9	2.0	0.2	0.0	1.1	0.7	0.0	0.2	99.3	249.1	2.7	4.1	0.3	1.9	702.5	8.1	0.8	5.4	10.3	0.8	8.5	2.1	125.2	270.7	0.9	3.4	12.8	1.7	35.8	0.1	0.1	0.0	15.1	6.6	1.6	9.1	15.8	10.7	0.2	0.4	0.0	11.9	0.3	4.9	2.3
LGI3		ENSG00000168481	"Leucine rich repeat LGI family member 3"	Q8N145	8	22146830-22157084	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	Exocytosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"brain: 112.6"	"Group enriched"	"Detected in some"	4	"Alveolar cells type 2: 22.2;Excitatory neurons: 17.7;Inhibitory neurons: 23.7;Melanocytes: 40.9;Oligodendrocytes: 58.4"	"Group enriched"	"Detected in many"	5	"glioma: 4.7;melanoma: 14.3;thyroid cancer: 4.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 1.1;SCLC-21H: 1.6;SK-MEL-30: 1.6;WM-115: 1.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024826			Approved	Cytosol	"Secreted in brain"	NA	NA				"Cluster 70: Brain - Nervous system development"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Cytosol		"HPA024826: AB_10601131"	"unprognostic (4.41e-2)"	"unprognostic (1.78e-1)"	"unprognostic (3.28e-1)"	"unprognostic (8.11e-3)"	"unprognostic (1.14e-1)"	"unprognostic (7.45e-2)"	"unprognostic (3.38e-1)"	"unprognostic (2.43e-2)"	"unprognostic (9.64e-2)"	"unprognostic (1.64e-2)"	"unprognostic (6.25e-3)"	"unprognostic (1.26e-2)"	"unprognostic (5.59e-5)"	"unprognostic (1.36e-2)"	"unprognostic (9.41e-2)"	"unprognostic (4.80e-2)"	"unprognostic (4.14e-2)"	0.3	3.4	44.2	0.1	79.7	0.1	0.2	81.1	84.6	2.9	5.2	0.8	0.3	1.2	0.3	6.5	1.6	0.1	2.2	43.4	70.4	0.4	0.1	15.9	0.0	85.8	72.4	0.2	0.8	0.3	2.8	0.0	90.7	1.3	0.1	3.9	1.7	2.8	0.2	15.0	0.5	0.6	57.1	0.1	0.9	0.8	86.3	0.3	13.0	0.1	0.3	0.2	2.5	112.6	0.0	1.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.7	0.3	0.2	0.1	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	1.6	0.2	0.0	0.0	1.6	0.0	0.1	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.0	0.0	0.3	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	44.2	79.7	81.1	84.6	43.4	70.4	85.8	72.4	90.7	57.1	86.3	112.6	0.0	0.0	22.2	2.0	0.0	2.3	0.0	0.0	0.0	2.7	0.1	0.0	4.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	1.8	0.0	17.7	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.7	0.0	0.0	0.0	0.4	0.0	0.3	0.1	40.9	2.8	0.0	1.2	0.0	6.6	58.4	0.1	0.0	7.2	0.0	0.0	0.0	0.8	0.0	2.9	0.0	0.0	0.6	0.1	0.1	1.4	0.6	0.0	0.0	0.9	0.0	0.0
LHFPL4	GARLH4	ENSG00000156959	"LHFPL tetraspan subfamily member 4"	Q7Z7J7	3	9498361-9553822	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"brain: 15.5;pituitary gland: 12.2;retina: 9.3"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 42.4;Cone photoreceptor cells: 18.8;Excitatory neurons: 60.0;Inhibitory neurons: 67.2;Oligodendrocyte precursor cells: 34.2;Rod photoreceptor cells: 17.4"	"Group enriched"	"Detected in some"	4	"glioma: 6.8;testis cancer: 5.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"GAMG: 13.5;NTERA-2: 4.4;SCLC-21H: 10.0;SH-SY5Y: 12.5;U-266/84: 11.3;WM-115: 3.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041421	Uncertain		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA				"Cluster 58: Brain - Synaptic function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 56: Bipolar cells - Visual perception"	"Golgi apparatus"	Nucleoplasm	"HPA041421: AB_10796673"	"unprognostic (6.81e-2)"	"unprognostic (3.65e-2)"	"unprognostic (4.50e-1)"	"unprognostic (6.62e-3)"	"unprognostic (1.82e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.60e-1)"	"unprognostic (5.65e-2)"	"unprognostic (6.59e-2)"	"unprognostic (1.12e-2)"	"unprognostic (3.77e-1)"	"unprognostic (1.90e-2)"	"unprognostic (6.78e-2)"	"unprognostic (2.99e-1)"	"unprognostic (3.03e-3)"	"unprognostic (8.21e-2)"	0.0	2.0	11.1	0.0	11.4	0.0	0.0	7.1	15.5	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	11.3	12.7	0.0	0.0	0.0	0.0	10.4	7.4	0.0	0.5	0.1	12.2	0.0	10.2	0.0	0.2	9.3	0.0	0.0	0.0	0.1	0.2	0.0	3.3	0.0	0.2	0.7	12.1	0.0	0.0	0.0	0.0	0.0	0.0	9.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.5	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	1.5	0.0	0.0	0.0	0.0	0.0	0.0	10.0	12.5	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.1	2.9	0.0	11.3	0.0	0.5	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	11.1	11.4	7.1	15.5	11.3	12.7	10.4	7.4	10.2	3.3	12.1	9.8	0.4	0.0	0.0	4.6	0.5	0.0	2.9	0.0	0.0	42.4	0.4	0.3	0.8	0.0	0.0	0.0	18.8	0.6	0.6	0.6	0.0	0.3	0.6	0.7	1.1	0.8	1.2	0.0	60.0	0.2	1.4	0.6	0.0	1.3	1.3	0.5	4.2	0.2	0.3	15.2	67.2	0.7	0.0	0.3	0.0	0.7	0.0	0.8	0.0	1.0	0.1	2.0	3.1	34.2	5.6	0.4	1.7	0.0	0.0	6.3	0.8	0.2	0.0	17.4	0.0	2.7	0.4	1.7	1.1	0.0	0.0	1.4	0.4	0.3	0.8	2.5
LMNTD1	"FLJ36004, IFLTD1, Pas1c1"	ENSG00000152936	"Lamin tail domain containing 1"	Q8N9Z9	12	25409307-25648579	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 14.7;fallopian tube: 17.0;testis: 14.8"	"Group enriched"	"Detected in some"	4	"Astrocytes: 15.0;Early spermatids: 49.0;Endometrial ciliated cells: 17.6;Late spermatids: 40.6;Respiratory ciliated cells: 14.6"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 6.2;RT4: 7.7;SH-SY5Y: 7.6;U-2197: 26.8"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA038640			Approved	Nucleoplasm,Centrosome		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 18: U-2197 - ECM organization"	"Cluster 49: Ciliated cells - Cilium organization"	"Nucleoplasm, Centrosome"		"HPA038640: AB_2676127"				"unprognostic (8.92e-3)"	"unprognostic (3.21e-1)"			"unprognostic (2.41e-1)"		"unprognostic (1.19e-2)"	"unprognostic (9.57e-2)"	"unprognostic (1.68e-1)"		"unprognostic (6.18e-2)"	"unprognostic (2.42e-1)"	"unprognostic (7.80e-2)"	"unprognostic (3.89e-2)"	0.4	0.1	4.0	0.7	5.8	0.3	0.9	6.1	3.9	0.5	3.7	3.6	1.4	0.7	0.6	0.3	17.0	0.8	0.2	5.2	6.0	0.7	0.2	1.3	0.3	12.5	14.7	0.2	0.5	0.0	0.7	0.2	8.3	0.2	3.4	1.2	0.0	0.2	0.2	0.4	0.6	1.1	8.8	0.6	0.6	14.8	5.8	0.2	0.9	0.0	0.2	0.3	0.0	9.8	0.4	0.3	0.0	0.2	0.2	1.6	2.7	3.3	6.2	1.4	0.2	0.0	0.4	0.2	0.1	0.0	3.9	0.1	0.3	0.1	0.3	1.1	0.1	1.1	0.9	2.3	0.3	0.1	0.1	0.5	0.2	1.8	0.5	0.1	0.1	0.0	2.3	0.4	0.0	0.5	0.0	0.4	1.8	0.1	0.6	0.5	0.2	0.2	0.2	7.7	0.2	7.6	0.1	0.4	4.3	0.9	0.3	1.8	0.3	0.2	1.0	26.8	0.3	0.8	1.6	1.8	0.3	1.8	2.9	0.5	0.1	0.1	0.2	0.0	0.1	0.4	0.2	0.2	0.1	0.5	0.2	0.3	0.5	0.1	0.0	0.5	0.1	0.1	4.0	5.8	6.1	3.9	5.2	6.0	12.5	14.7	8.3	8.8	5.8	9.8	0.1	0.0	0.0	15.0	0.1	0.0	2.4	0.0	0.0	0.0	0.2	0.3	0.6	0.0	1.3	0.0	0.0	0.3	0.0	0.0	1.9	0.0	49.0	17.6	0.1	0.1	0.0	0.0	1.5	0.0	0.3	0.3	0.0	0.2	0.0	0.7	0.0	0.4	0.1	0.0	1.0	0.0	0.0	0.3	0.0	40.6	0.0	0.3	0.0	5.6	0.0	0.0	0.0	1.5	0.7	0.0	0.0	0.0	0.0	1.0	0.0	0.1	14.6	0.0	0.0	0.7	0.1	1.1	0.4	0.0	0.0	0.3	0.1	0.0	0.0	0.9
LRRC10B		ENSG00000204950	"Leucine rich repeat containing 10B"	A6NIK2	11	61508749-61511018	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"brain: 42.4;fallopian tube: 28.7;pituitary gland: 33.7"	"Cell type enhanced"	"Detected in some"		"Endometrial ciliated cells: 49.3;Muller glia cells: 9.5;Respiratory ciliated cells: 37.2;Sertoli cells: 19.7;Smooth muscle cells: 20.6"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 5.8"	"Region enhanced"	"Detected in many"		"basal ganglia: 42.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"AF22: 9.7;RH-30: 10.5;SCLC-21H: 5.4"	"Region enriched"	"Detected in many"	7	"basal ganglia: 222.5"	"Group enriched"	"Detected in many"	5	"basal ganglia: 30.9;hippocampal formation: 24.2"	HPA047619	Uncertain		Approved	Nucleoplasm,Nucleoli		No	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 12: NES - Nervous system development"	"Cluster 49: Ciliated cells - Cilium organization"	Nucleoplasm	Nucleoli	"HPA047619: AB_2680106"	"unprognostic (9.95e-2)"	"unprognostic (2.67e-2)"	"unprognostic (4.92e-2)"	"unprognostic (1.26e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.32e-1)"	"unprognostic (6.10e-2)"	"unprognostic (9.22e-2)"	"unprognostic (4.88e-3)"	"unprognostic (1.62e-1)"	"unprognostic (9.21e-3)"	"unprognostic (2.52e-2)"	"unprognostic (5.27e-4)"	"unprognostic (5.07e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.38e-1)"	"unprognostic (6.63e-2)"	3.7	0.9	11.1	0.4	42.4	0.0	2.9	0.5	11.2	5.9	3.6	2.2	0.3	4.9	1.9	0.5	28.7	0.3	1.7	13.5	5.2	2.2	0.1	4.9	0.0	4.0	4.0	2.3	1.3	2.2	33.7	0.5	2.1	1.6	0.3	0.1	1.3	0.5	0.7	0.9	1.4	1.6	3.1	0.4	2.9	5.9	7.9	2.7	1.6	0.9	0.0	1.1	2.5	3.4	0.0	0.0	9.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.1	0.8	0.0	0.2	0.0	0.0	0.0	10.5	0.0	0.0	0.0	5.4	0.5	0.2	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.1	42.4	0.5	11.2	13.5	5.2	4.0	4.0	2.1	3.1	7.9	3.4	0.9	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.6	0.6	0.4	1.1	0.0	3.5	1.8	0.0	0.0	0.0	0.1	0.0	0.0	3.2	49.3	0.5	0.4	4.2	0.0	1.0	0.0	0.0	0.4	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.8	6.1	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	9.5	0.0	0.5	0.1	0.1	0.1	0.0	0.0	0.3	0.0	0.0	37.2	0.2	19.7	0.7	20.6	0.8	1.1	0.0	0.3	0.1	0.1	0.2	0.1	0.1
MAP6	"FLJ41346, KIAA1878, MAP6-N, STOP"	ENSG00000171533	"Microtubule associated protein 6"	Q96JE9	11	75586918-75669038	"Predicted intracellular proteins"	Transport	Calmodulin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pituitary gland: 76.8;retina: 96.1"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 81.2;Cone photoreceptor cells: 158.4;Excitatory neurons: 75.8;Horizontal cells: 50.5;Inhibitory neurons: 43.3;Late spermatids: 41.9"	"Cancer enhanced"	"Detected in many"		"glioma: 9.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"AF22: 37.8;CACO-2: 38.1;HDLM-2: 21.5;SCLC-21H: 62.4;SH-SY5Y: 31.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB015442, CAB022600, HPA039061, HPA039062"	Enhanced		Uncertain	"Plasma membrane"		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 77: Retina - Visual perception"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 56: Bipolar cells - Visual perception"	"Plasma membrane"		"CAB015442: AB_2140997, CAB022600: , HPA039061: AB_2676325, HPA039062: AB_2676326"	"unprognostic (3.04e-2)"	"unprognostic (6.18e-2)"	"unprognostic (3.15e-2)"	"unprognostic (9.07e-2)"	"unprognostic (7.54e-2)"	"unprognostic (4.49e-2)"	"unprognostic (8.29e-2)"	"unprognostic (2.51e-2)"	"unprognostic (5.99e-2)"	"unprognostic (7.99e-2)"	"prognostic favorable (3.41e-4)"	"prognostic favorable (9.15e-4)"	"unprognostic (2.43e-2)"	"unprognostic (3.96e-3)"	"unprognostic (8.09e-3)"	"unprognostic (1.77e-1)"	"unprognostic (2.03e-1)"	4.8	19.0	68.3	2.0	68.0	0.0	3.5	50.7	70.6	10.6	64.4	23.0	1.7	18.1	21.0	4.2	40.7	6.4	8.6	67.7	71.5	17.0	1.2	7.8	0.7	70.2	64.6	8.0	3.6	22.0	76.8	1.5	70.8	17.8	3.5	96.1	3.6	21.1	1.0	8.1	4.8	13.1	52.9	2.4	10.7	18.6	68.5	0.8	7.9	1.3	0.5	7.1	8.4	59.7	0.2	0.7	37.8	0.1	0.1	0.0	0.0	3.8	0.2	0.3	0.0	38.1	0.1	0.6	1.4	6.3	1.3	0.0	3.4	0.5	0.0	21.5	0.5	0.0	0.0	0.0	1.0	0.0	0.0	2.1	0.5	0.1	0.2	5.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	5.9	0.0	2.9	0.0	0.0	0.1	0.1	0.5	62.4	31.7	4.6	0.0	0.0	0.8	0.0	0.0	0.9	0.0	0.1	0.1	0.5	0.0	0.0	0.0	6.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	68.3	68.0	50.7	70.6	67.7	71.5	70.2	64.6	70.8	52.9	68.5	59.7	1.2	3.2	3.7	25.8	0.1	0.8	1.7	0.7	0.0	81.2	0.8	1.8	8.4	1.5	3.1	11.0	158.4	0.2	0.2	0.0	1.9	0.1	27.7	28.2	4.6	1.6	13.1	0.0	75.8	0.2	0.0	2.9	0.0	0.8	0.0	0.8	2.2	0.3	0.1	50.5	43.3	0.0	6.1	0.0	1.1	41.9	7.5	0.3	5.4	1.9	0.0	18.7	0.0	13.0	13.3	0.2	0.0	18.4	0.1	1.4	0.0	1.2	25.4	10.2	0.0	1.9	5.7	23.5	4.3	0.1	0.4	0.0	0.3	0.1	0.0	0.4
MAST1	"KIAA0973, SAST"	ENSG00000105613	"Microtubule associated serine/threonine kinase 1"	Q9Y2H9	19	12833951-12874952	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 37.7;pituitary gland: 23.3;retina: 15.4"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 24.7;Cone photoreceptor cells: 43.8;Excitatory neurons: 64.7;Inhibitory neurons: 70.3;Oligodendrocyte precursor cells: 22.1;Rod photoreceptor cells: 20.4"	"Cancer enhanced"	"Detected in many"		"glioma: 3.5"	"Region enhanced"	"Detected in many"		"cerebral cortex: 37.7"	"Immune cell enhanced"	"Detected in single"		"MAIT T-cell: 1.0"	"Lineage enriched"	"Detected in single"	9	"T-cells: 1.0"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 23.3;SCLC-21H: 40.5;SH-SY5Y: 20.2;U-266/70: 16.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028181, HPA073106"	Enhanced		Supported	Vesicles,Cytosol		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 58: Brain - Synaptic function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Vesicles	Cytosol	"HPA028181: AB_10603872, HPA073106: AB_2732218"	"unprognostic (6.32e-2)"	"unprognostic (3.66e-2)"	"unprognostic (3.93e-2)"	"unprognostic (2.83e-5)"	"unprognostic (1.72e-1)"	"unprognostic (4.19e-2)"	"unprognostic (2.38e-1)"	"unprognostic (8.72e-2)"	"unprognostic (1.04e-1)"	"unprognostic (3.64e-1)"	"unprognostic (8.89e-3)"	"unprognostic (3.43e-2)"	"unprognostic (3.84e-3)"	"unprognostic (1.19e-1)"	"unprognostic (7.04e-2)"	"unprognostic (2.49e-2)"	"unprognostic (1.96e-1)"	0.0	2.2	6.5	0.3	12.1	0.3	0.1	7.3	37.7	0.2	0.0	1.2	0.3	0.0	0.0	0.2	0.1	0.2	0.2	8.3	2.4	0.1	0.6	0.1	0.1	11.2	1.1	0.3	0.6	0.5	23.3	0.0	9.5	0.2	0.1	15.4	0.2	0.0	0.0	3.7	0.4	0.0	0.0	0.1	0.6	5.0	1.2	0.8	0.1	0.0	0.0	0.2	0.3	3.0	3.6	1.6	1.5	23.3	0.0	0.0	1.9	0.2	0.1	0.3	0.9	0.8	1.5	5.8	2.6	0.0	3.9	0.1	6.8	0.1	0.1	4.1	4.5	0.5	5.8	2.6	0.0	1.3	1.2	0.5	0.1	0.8	0.7	1.3	0.0	15.2	5.2	3.0	0.0	0.8	2.4	0.6	6.9	0.6	7.2	15.9	4.6	8.3	0.3	0.2	40.5	20.2	0.8	1.4	4.3	1.2	3.8	2.1	0.0	2.8	4.2	3.1	0.8	16.7	14.5	3.7	5.1	3.1	0.1	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	6.5	12.1	7.3	37.7	8.3	2.4	11.2	1.1	9.5	0.0	1.2	3.0	0.5	0.0	2.4	7.8	0.2	0.9	1.6	0.6	0.6	24.7	0.8	2.5	1.0	0.0	0.3	0.0	43.8	0.6	0.4	0.6	0.0	0.4	14.0	0.2	0.2	1.3	0.0	0.0	64.7	0.5	0.6	1.3	0.0	0.3	1.3	0.5	1.1	0.5	0.2	15.2	70.3	0.1	0.0	1.0	1.2	8.2	0.6	0.7	5.4	6.5	0.1	3.7	0.0	22.1	3.0	0.3	2.5	1.2	0.0	1.0	0.9	0.2	1.0	20.4	0.0	2.0	0.5	8.0	5.2	0.7	1.4	0.3	1.0	0.4	0.7	1.2
MCF2L2	"ARHGEF22, KIAA0861"	ENSG00000053524	"MCF.2 cell line derived transforming sequence-like 2"	Q86YR7	3	183178043-183428778	"Disease related genes, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"	"Diabetes mellitus"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 33.5;retina: 28.2"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 79.0;Cone photoreceptor cells: 221.0;Early spermatids: 92.9;Excitatory neurons: 177.2;Inhibitory neurons: 149.9;Oligodendrocyte precursor cells: 185.5;Oligodendrocytes: 69.1;Rod photoreceptor cells: 124.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	5	"T-reg: 1.6"	"Lineage enriched"	"Detected in single"	15	"T-cells: 1.6"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 6.0;Karpas-707: 5.0;REH: 3.4"					"Low region specificity"	"Detected in all"			"HPA038946, HPA038947, HPA061485"	Uncertain		Approved	"Centriolar satellite,Cytosol"		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 58: Brain - Synaptic function"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Centriolar satellite, Cytosol"		"HPA038946: AB_10670914, HPA038947: AB_10672655, HPA061485: "	"unprognostic (2.17e-2)"	"unprognostic (4.42e-1)"	"unprognostic (3.08e-1)"	"unprognostic (1.95e-3)"	"unprognostic (1.98e-1)"	"unprognostic (2.87e-2)"	"unprognostic (3.70e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.46e-1)"	"unprognostic (5.08e-2)"	"unprognostic (4.80e-4)"	"unprognostic (1.32e-1)"	"unprognostic (8.75e-6)"	"unprognostic (1.09e-1)"	"unprognostic (5.47e-2)"	"unprognostic (2.95e-1)"	"unprognostic (1.78e-1)"	0.1	7.7	9.4	0.3	16.5	0.2	0.1	0.3	33.5	0.3	0.0	0.5	0.0	0.2	0.2	0.2	0.2	0.3	0.2	13.5	6.5	0.4	0.0	0.2	0.5	6.9	6.1	0.2	0.2	3.8	5.4	0.0	7.2	0.6	0.3	28.2	0.1	0.4	0.3	0.2	0.3	0.3	0.0	2.5	0.2	2.6	5.6	0.3	0.1	0.2	0.7	0.4	0.3	19.8	0.0	0.4	0.1	1.1	0.0	0.1	0.2	0.0	0.0	0.2	0.0	0.7	0.1	1.0	0.1	0.0	1.2	0.0	0.2	0.1	0.0	6.0	0.9	2.5	0.2	0.0	0.1	0.8	0.5	0.1	0.0	0.0	0.4	0.0	0.4	1.5	0.8	5.0	0.3	0.7	0.8	0.5	0.8	0.0	1.0	3.4	0.0	0.9	0.2	0.1	1.5	0.5	0.6	0.0	1.3	0.3	0.3	0.5	0.3	0.0	0.5	0.0	0.0	2.0	2.3	1.1	0.5	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.3	0.2	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	1.6	0.0	9.4	16.5	0.3	33.5	13.5	6.5	6.9	6.1	7.2	0.0	5.6	19.8	12.3	0.0	2.2	17.0	0.2	0.4	0.5	0.2	8.6	79.0	0.3	0.6	1.8	0.0	0.1	5.5	221.0	0.2	0.8	2.1	0.0	0.1	92.9	4.6	2.1	2.0	0.0	0.4	177.2	0.2	0.1	2.0	5.1	4.3	1.3	7.7	1.8	0.4	0.5	8.4	149.9	0.3	2.0	0.8	1.2	16.4	0.9	4.3	1.8	43.1	1.6	3.8	1.0	185.5	69.1	0.1	2.2	0.4	0.6	0.3	0.4	0.1	2.8	124.0	0.0	4.1	0.9	1.4	4.2	11.2	0.4	1.4	2.9	2.9	0.2	1.1
MRAP2	"bA51G5.2, C6orf117"	ENSG00000135324	"Melanocortin 2 receptor accessory protein 2"	Q96G30	6	84033772-84090881	"Disease related genes, Human disease related genes, Predicted membrane proteins"			Obesity	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 20.0"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 56.5;Inhibitory neurons: 33.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"K-562: 91.7;SCLC-21H: 30.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"									NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 65: Brain - Ion transport"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"				"unprognostic (3.82e-4)"	"unprognostic (7.11e-2)"	"unprognostic (2.35e-1)"	"prognostic favorable (1.66e-4)"	"unprognostic (8.80e-3)"	"unprognostic (3.15e-1)"	"unprognostic (9.85e-2)"	"unprognostic (7.43e-2)"	"unprognostic (2.76e-1)"	"unprognostic (2.05e-3)"	"unprognostic (1.41e-2)"	"unprognostic (4.47e-1)"	"unprognostic (6.02e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.01e-2)"	"unprognostic (4.50e-3)"	"unprognostic (9.12e-2)"	1.0	7.3	10.5	1.3	9.5	0.1	1.6	4.9	20.0	2.6	3.6	5.3	3.7	2.5	1.1	1.4	8.6	1.9	1.1	8.3	11.3	3.4	0.2	0.9	0.5	8.4	8.5	4.6	4.3	0.1	3.6	0.2	8.7	6.1	5.1	2.1	6.9	7.8	1.3	1.9	3.9	1.1	3.8	8.6	7.6	2.8	18.6	0.9	0.6	0.5	1.7	0.8	2.2	13.0	0.0	2.5	0.9	0.0	0.3	1.4	0.1	0.9	0.0	1.5	0.2	1.2	0.1	0.2	0.1	9.6	3.2	0.0	1.7	0.4	0.1	0.8	0.8	3.1	0.2	0.4	0.0	0.7	0.2	0.4	1.3	0.1	0.0	0.1	5.7	0.1	91.7	0.1	0.4	0.0	0.0	0.0	2.1	0.0	0.4	0.1	5.0	0.0	5.3	1.6	30.1	10.2	0.2	0.0	1.5	1.1	0.2	2.6	0.4	0.5	0.4	5.0	1.2	0.0	0.0	0.0	0.0	0.1	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	10.5	9.5	4.9	20.0	8.3	11.3	8.4	8.5	8.7	3.8	18.6	13.0	0.8	0.0	0.5	3.3	0.0	1.8	7.8	1.7	0.6	1.2	0.8	1.0	0.2	1.5	2.1	12.9	0.0	0.1	0.1	6.4	1.9	4.3	2.8	5.1	0.5	2.3	0.0	0.0	56.5	5.3	0.0	1.1	13.7	2.4	0.0	1.8	4.2	0.0	0.0	0.0	33.5	11.3	0.0	0.0	0.4	4.8	4.1	0.2	0.0	2.8	0.0	0.4	0.0	3.5	4.0	0.6	6.4	5.3	0.0	2.8	2.3	0.0	4.5	0.5	0.0	8.1	2.4	0.2	4.7	2.7	1.0	0.0	0.1	1.8	6.8	4.7
NDRG4	"KIAA1180, SMAP-8"	ENSG00000103034	"NDRG family member 4"	Q9ULP0	16	58462846-58513628	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 380.7;heart muscle: 352.7"	"Group enriched"	"Detected in many"	4	"Cardiomyocytes: 433.0;Horizontal cells: 516.5"	"Cancer enriched"	"Detected in many"	6	"glioma: 23.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"EFO-21: 32.5;GAMG: 28.6;hTERT-RPE1: 26.8;HUVEC TERT2: 21.0;SCLC-21H: 49.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015313, HPA017587"	Enhanced		Uncertain	Nucleoplasm,Cytosol		NA	NA				"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 62: Horizontal cells - Visual perception"	"Nucleoplasm, Cytosol"		"HPA015313: AB_1854343, HPA017587: AB_1854344"	"unprognostic (1.52e-1)"	"unprognostic (1.30e-1)"	"unprognostic (9.03e-3)"	"unprognostic (1.59e-2)"	"unprognostic (3.97e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.82e-3)"	"unprognostic (1.56e-1)"	"unprognostic (6.07e-2)"	"unprognostic (1.02e-1)"	"unprognostic (4.84e-3)"	"unprognostic (5.98e-2)"	"unprognostic (2.27e-2)"	"unprognostic (1.22e-2)"	"unprognostic (8.51e-2)"	"unprognostic (4.45e-2)"	"unprognostic (7.17e-2)"	16.4	128.8	122.7	2.9	136.0	0.1	11.4	239.4	248.6	25.3	0.0	6.5	3.7	25.5	6.8	20.8	8.0	3.6	352.7	195.0	170.4	1.6	1.0	17.7	4.1	379.4	113.0	1.8	2.7	12.0	71.6	2.0	380.7	3.1	3.2	115.5	5.3	30.2	8.7	21.5	3.9	13.3	41.6	21.9	4.1	48.1	190.9	4.5	2.7	3.6	4.0	3.7	57.5	91.7	0.2	16.9	15.8	3.1	0.4	2.9	1.3	5.2	8.2	2.5	1.7	6.5	4.3	0.4	32.5	4.0	28.6	1.5	1.2	0.9	2.2	0.0	3.3	0.7	3.3	4.7	4.4	0.3	0.3	3.6	0.3	1.6	0.0	26.8	21.0	0.1	0.3	0.2	2.4	4.3	1.7	0.2	1.4	0.6	12.4	0.4	4.4	0.4	0.7	10.6	49.2	18.4	0.5	1.4	0.1	2.0	0.6	0.2	7.7	2.1	6.0	0.6	0.8	0.9	0.5	5.7	11.4	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	122.7	136.0	239.4	248.6	195.0	170.4	379.4	113.0	380.7	41.6	190.9	91.7	8.9	0.0	1.9	53.5	0.2	2.0	6.8	0.6	1.2	52.3	0.7	1.5	433.0	0.0	0.3	0.0	4.2	0.0	0.1	0.6	0.0	4.0	5.9	4.0	5.6	17.0	1.8	0.0	95.7	0.2	0.1	10.1	1.5	11.5	0.0	13.6	29.3	0.3	0.0	516.5	94.3	0.1	2.0	1.0	1.2	10.8	4.4	0.3	7.2	22.5	0.0	82.6	0.0	29.7	14.1	3.7	0.0	2.6	0.0	4.9	0.0	0.2	0.2	33.4	6.6	3.5	6.7	4.8	6.5	14.5	5.8	0.0	0.3	0.3	0.0	8.8
NSG1	"D4S234E, NEEP21, P21"	ENSG00000168824	"Neuronal vesicle trafficking associated 1"	P42857	4	4348140-4419058	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 95.7;pituitary gland: 135.1;skin 1: 120.9"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 222.4;Cytotrophoblasts: 120.2;Granulosa cells: 128.8;Melanocytes: 291.7;Suprabasal keratinocytes: 178.2"	"Cancer enriched"	"Detected in many"	4	"melanoma: 61.4"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"gdT-cell: 45.2;MAIT T-cell: 61.9;memory CD4 T-cell: 42.2;memory CD8 T-cell: 37.1;naive CD8 T-cell: 27.6"	"Lineage enriched"	"Detected in many"	57	"T-cells: 61.9"	"Cell line enhanced"	"Detected in many"		"HAP1: 84.7;SCLC-21H: 168.6;SH-SY5Y: 82.5;SK-MEL-30: 80.9;TIME: 204.6;U-698: 75.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 52: Non-specific - Transcription"				"unprognostic (3.21e-3)"	"unprognostic (2.33e-1)"	"unprognostic (5.29e-3)"	"unprognostic (7.60e-2)"	"unprognostic (8.06e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.32e-3)"	"unprognostic (3.47e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.91e-3)"	"prognostic favorable (9.49e-4)"	"unprognostic (2.50e-1)"	"unprognostic (6.85e-2)"	"unprognostic (4.21e-2)"	"unprognostic (7.33e-2)"	"unprognostic (2.85e-1)"	"unprognostic (7.41e-2)"	5.0	25.3	29.0	4.2	33.1	1.0	6.0	59.6	50.7	17.1	5.3	7.9	6.8	7.8	2.1	30.7	20.1	1.3	5.9	18.4	95.7	4.4	0.5	1.5	3.2	57.1	64.8	46.3	1.8	0.1	135.1	18.3	58.8	22.8	7.1	32.3	6.7	18.2	0.7	120.9	5.8	6.9	24.2	2.2	8.0	16.0	45.4	9.5	0.5	3.0	3.5	13.3	30.1	24.2	0.2	0.1	0.8	0.5	0.0	0.0	14.6	0.3	0.0	0.2	0.0	1.3	0.4	0.0	10.4	0.5	3.3	2.4	84.7	5.5	0.4	0.0	3.0	0.0	0.2	0.0	4.1	0.0	0.0	0.1	12.0	0.0	2.3	0.0	14.6	22.3	0.0	0.1	1.3	0.0	6.8	0.5	10.1	0.1	0.4	0.1	0.0	0.4	0.0	4.8	168.6	82.5	0.6	0.2	80.9	7.0	0.9	0.3	204.6	0.0	13.0	0.2	0.3	0.1	0.4	75.9	0.1	0.2	0.4	0.2	0.1	0.1	45.2	0.1	61.9	0.1	42.2	37.1	0.1	0.1	10.4	27.6	1.0	0.9	0.2	0.1	4.5	15.7	29.0	33.1	59.6	50.7	18.4	95.7	57.1	64.8	58.8	24.2	45.4	24.2	1.6	9.6	0.0	5.9	0.4	86.8	83.4	47.9	31.3	222.4	0.7	24.3	0.0	0.0	13.2	0.0	4.2	120.2	6.0	0.0	0.0	0.0	31.2	10.3	1.4	2.1	2.4	0.0	16.6	0.0	15.2	24.9	0.0	16.4	1.3	128.8	1.8	0.0	8.2	8.4	32.2	0.0	4.1	0.0	13.6	44.2	3.1	1.3	291.7	6.5	0.4	6.4	20.6	1.5	4.0	0.1	0.2	5.7	0.7	19.9	0.0	20.4	1.7	24.3	0.0	0.2	10.8	2.9	14.4	44.8	178.2	76.8	17.0	96.0	0.3	77.0
OPRD1		ENSG00000116329	"Opioid receptor delta 1"	P41143	1	28812142-28871267	"FDA approved drug targets, G-protein coupled receptors, Human disease related genes, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 4.7"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 3.7;Excitatory neurons: 11.8;Inhibitory neurons: 15.7;Skeletal myocytes: 2.6"	"Cancer enhanced"	"Detected in single"		"melanoma: 1.0"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	11	"RH-30: 16.4;SCLC-21H: 6.4;SH-SY5Y: 6.5;WM-115: 22.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA070831	Approved					NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA070831: AB_2732167"	"unprognostic (1.44e-1)"	"unprognostic (4.07e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.89e-2)"	"unprognostic (2.68e-1)"	"unprognostic (5.84e-3)"	"unprognostic (6.28e-3)"	"unprognostic (5.92e-2)"	"unprognostic (1.82e-2)"	"unprognostic (5.95e-3)"	"unprognostic (4.28e-3)"	"unprognostic (2.98e-1)"	"unprognostic (1.52e-7)"	"unprognostic (1.44e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.26e-1)"	"unprognostic (2.18e-3)"	0.1	0.5	1.4	0.1	1.6	0.4	0.0	0.0	3.2	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.1	0.0	1.9	0.0	0.0	0.0	0.1	0.1	4.4	0.1	0.1	0.3	0.0	0.1	0.1	4.7	0.1	0.1	0.5	0.2	0.0	1.0	0.2	0.1	0.0	0.0	0.1	0.1	0.2	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.1	0.3	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.5	0.2	0.2	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.3	0.2	0.1	0.0	0.2	1.0	0.0	0.0	0.0	16.4	0.1	0.0	0.1	6.4	6.5	0.0	0.1	1.1	0.3	0.1	0.1	0.0	0.1	0.3	0.2	0.0	0.2	0.0	0.2	0.1	0.4	22.0	0.9	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.2	0.1	0.1	0.5	0.2	0.0	0.2	0.0	0.0	1.4	1.6	0.0	3.2	1.9	0.0	4.4	0.1	4.7	0.0	0.2	0.8	0.0	0.0	0.0	0.0	0.2	0.0	1.0	0.0	0.0	3.7	0.1	0.1	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.5	0.0	0.0	11.8	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	15.7	0.0	0.0	0.0	0.0	0.4	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.5	0.3	0.1	0.0	0.0	0.0	1.1	0.0	0.1	0.0	0.4	0.0	2.6	0.3	0.0	0.7	0.0	0.0	0.0	0.3	0.1	0.0	1.2
OXGR1	"aKGR, GPR80, GPR99, P2RY15, P2Y15"	ENSG00000165621	"Oxoglutarate receptor 1"	Q96P68	13	96985719-96994730	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	13	"Extravillous trophoblasts: 49.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	6	"myeloid DC: 1.2;plasmacytoid DC: 2.1"	"Lineage enriched"	"Detected in single"	7	"dendritic cells: 2.1"	"Cell line enhanced"	"Detected in some"		"RT4: 3.3;SK-BR-3: 1.4;U-2 OS: 1.6"	"Not detected"	"Not detected"							HPA067673			Supported	"Plasma membrane"		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 15: RT4 - Unknown function"	"Cluster 38: Extravillous trophoblasts - Unknown function"	"Plasma membrane"		"HPA067673: AB_2685883"	"unprognostic (1.83e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.33e-1)"	"unprognostic (6.97e-4)"	"unprognostic (7.23e-2)"	"unprognostic (1.52e-1)"		"unprognostic (8.38e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.22e-2)"	"unprognostic (4.14e-2)"	"unprognostic (3.88e-2)"	"unprognostic (1.89e-1)"	"unprognostic (2.75e-1)"	"unprognostic (1.54e-1)"	"unprognostic (9.68e-2)"	1.3	0.0	1.0	1.3	0.8	0.1	4.2	0.5	1.5	1.0	0.5	2.0	0.2	0.5	2.5	2.1	1.6	0.1	0.2	0.8	2.1	4.0	0.0	0.4	0.1	1.2	1.3	0.1	0.5	0.3	0.3	0.9	1.0	0.5	1.6	0.0	3.0	0.4	0.2	2.6	0.4	0.5	0.7	0.4	0.2	0.1	2.6	0.3	0.5	0.3	0.8	1.7	0.6	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	3.3	0.0	0.1	0.0	1.4	0.0	0.0	0.7	0.0	0.0	0.0	1.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.1	1.0	0.8	0.5	1.5	0.8	2.1	1.2	1.3	1.0	0.7	2.6	1.3	0.8	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.6	0.0	1.7	1.4	0.2	0.0	0.0	0.0	0.0	2.4	0.1	0.2	1.9	0.0	0.2	0.7	0.1	0.8	1.2	0.0	0.6	0.0	49.7	0.1	0.0	0.1	0.0	0.0	0.0	0.0	1.8	0.0	0.6	0.5	0.0	0.0	0.4	0.1	0.0	0.3	3.6	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.9	0.0	0.0	2.2	0.0	3.7	0.0	0.0	1.2	0.0
P2RX2	"DFNA41, P2X2"	ENSG00000187848	"Purinergic receptor P2X 2"	Q9UBL9	12	132618776-132622388	"Disease related genes, Human disease related genes, Predicted membrane proteins"	"Hearing, Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"	"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 11.3;epididymis: 21.8;prostate: 14.1"	"Cell type enhanced"	"Detected in some"		"Breast glandular cells: 1.6;Endometrial ciliated cells: 2.6;Fibroblasts: 8.3;Gastric mucus-secreting cells: 1.1;Peritubular cells: 3.0"	"Cancer enhanced"	"Detected in some"		"testis cancer: 1.3"	"Group enriched"	"Detected in many"	7	"amygdala: 9.2;cerebral cortex: 11.3;hippocampal formation: 10.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"MCF7: 5.1;T-47d: 11.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"									NA	NA				"Cluster 68: Epididymis - Unknown function"	"Cluster 6: T47d - Mammary gland"	"Cluster 50: Fibroblasts - ECM organization"				"unprognostic (1.12e-1)"	"unprognostic (1.49e-2)"	"unprognostic (5.92e-2)"	"unprognostic (5.94e-2)"	"unprognostic (2.79e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.12e-1)"	"unprognostic (5.79e-3)"	"unprognostic (6.75e-2)"	"unprognostic (2.92e-1)"	"unprognostic (1.11e-2)"	"unprognostic (3.66e-2)"	"unprognostic (1.88e-2)"	"unprognostic (6.21e-2)"	"unprognostic (3.05e-1)"		"unprognostic (9.12e-2)"	1.1	0.1	9.2	0.6	0.4	0.1	0.2	0.3	11.3	0.7	0.0	2.4	1.1	0.2	21.8	7.2	9.3	0.1	0.0	10.1	1.5	2.5	0.4	4.9	1.9	0.1	0.2	0.3	0.5	0.7	1.3	0.4	0.1	14.1	0.3	0.0	0.1	9.0	0.0	0.2	4.3	0.1	0.0	3.2	1.7	1.5	1.0	0.4	0.2	0.0	0.8	1.0	1.9	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.1	0.0	5.1	0.1	0.3	0.5	0.0	0.0	0.1	0.1	0.0	0.0	0.3	0.1	0.0	0.0	1.9	0.0	0.6	11.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.0	0.6	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	9.2	0.4	0.3	11.3	10.1	1.5	0.1	0.2	0.1	0.0	1.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.6	0.1	0.1	0.0	0.0	0.1	0.0	0.1	8.3	1.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	3.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.1
P2RX6	"MGC129625, P2RXL1, P2X6, P2XM"	ENSG00000099957	"Purinergic receptor P2X 6"	O15547	22	21009808-21028830	"Predicted membrane proteins"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 3.4;skeletal muscle: 12.4;tongue: 7.7"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 7.6;Excitatory neurons: 8.9;Inhibitory neurons: 7.9;Ionocytes: 8.2;Skeletal myocytes: 20.8"	"Group enriched"	"Detected in some"	5	"glioma: 1.0;melanoma: 2.2"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"hTERT-RPE1: 9.7;LHCN-M2: 6.7;RH-30: 4.2;U-87 MG: 11.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA028776, HPA028777"	Approved		Approved	Nucleoli,Cytosol		NA	NA				"Cluster 80: Striated muscle - Unknown function"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 50: Fibroblasts - ECM organization"	"Nucleoli, Cytosol"		"HPA028776: AB_2672771, HPA028777: AB_2672772"	"unprognostic (1.81e-2)"	"unprognostic (5.15e-3)"	"unprognostic (2.11e-2)"	"unprognostic (1.12e-1)"	"unprognostic (4.28e-2)"	"unprognostic (1.79e-5)"	"unprognostic (1.70e-2)"	"unprognostic (6.20e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.59e-2)"	"unprognostic (1.89e-2)"	"unprognostic (2.45e-2)"	"unprognostic (2.88e-10)"	"unprognostic (2.81e-1)"	"unprognostic (1.38e-1)"	"unprognostic (7.33e-2)"	"unprognostic (2.39e-3)"	0.3	1.1	0.0	0.3	0.2	0.0	0.1	1.0	2.6	0.1	0.4	0.1	0.0	0.2	0.0	0.2	0.3	0.8	1.3	1.0	1.5	0.2	0.1	0.3	0.2	3.4	0.4	0.3	0.1	0.0	1.3	0.8	3.4	0.3	0.0	0.3	0.2	0.7	12.4	0.1	0.1	0.1	0.1	1.6	0.2	1.1	0.6	0.0	0.0	7.7	0.0	0.2	0.1	1.2	0.0	0.4	0.7	0.2	0.1	0.0	0.8	0.1	1.7	0.7	1.2	0.0	0.0	0.0	1.1	0.4	2.9	1.3	0.0	0.1	0.1	0.2	0.0	1.9	0.9	0.0	2.8	0.0	2.4	0.3	0.0	1.2	0.0	9.7	0.0	0.0	2.1	0.6	6.7	0.0	0.0	0.3	0.0	0.0	0.0	0.0	4.2	0.2	0.0	0.0	0.2	3.1	1.2	0.1	0.5	0.1	0.0	0.0	0.0	2.1	0.3	0.0	0.0	0.2	0.0	0.0	11.7	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.0	2.6	1.0	1.5	3.4	0.4	3.4	0.1	0.6	1.2	0.2	0.0	0.6	0.3	0.1	0.1	0.8	0.8	0.6	7.6	0.0	0.4	2.4	0.0	0.2	1.8	0.0	0.5	0.0	0.1	0.0	0.0	2.2	1.8	0.5	0.2	3.5	2.7	8.9	0.0	0.4	1.4	0.0	0.7	2.5	0.1	1.8	0.1	0.1	1.7	7.9	0.7	8.2	0.0	0.0	1.4	0.0	0.1	0.0	0.0	0.0	1.1	0.0	5.0	3.3	0.0	0.0	0.4	0.1	0.2	0.0	0.3	3.2	1.1	0.0	20.8	0.4	1.6	0.4	0.3	0.1	0.4	0.5	0.1	0.1	0.2
PCSK1	"NEC1, PC1, PC3, SPC3"	ENSG00000175426	"Proprotein convertase subtilisin/kexin type 1"	P29120	5	96390333-96434143	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"	"Disease variant, Obesity"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"brain: 68.3"	"Cell type enriched"	"Detected in some"	4	"Enteroendocrine cells: 224.6"	"Cancer enhanced"	"Detected in many"		"breast cancer: 12.1"	"Group enriched"	"Detected in all"	5	"cerebral cortex: 19.1;hypothalamus: 68.3;pons: 30.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"SCLC-21H: 22.6;U-138 MG: 19.0;U-87 MG: 15.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA048564, HPA079656"	Approved				"Secreted in other tissues"	NA	NA				"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 17: Intestinal endocrine cells - Hormone signaling"			"HPA048564: AB_2680444, HPA079656: "	"unprognostic (1.86e-2)"	"unprognostic (2.13e-2)"	"unprognostic (4.66e-3)"	"unprognostic (8.20e-5)"	"prognostic unfavorable (9.13e-5)"	"unprognostic (8.47e-4)"	"unprognostic (1.46e-1)"	"unprognostic (5.84e-3)"	"unprognostic (4.71e-1)"	"unprognostic (3.07e-3)"	"unprognostic (1.89e-3)"	"unprognostic (1.01e-1)"	"unprognostic (7.90e-6)"	"unprognostic (5.25e-2)"	"unprognostic (9.96e-2)"	"unprognostic (1.33e-3)"	"unprognostic (9.37e-3)"	1.7	6.3	5.5	4.7	3.7	0.1	1.4	1.0	19.1	0.9	0.0	2.4	5.2	0.1	0.0	0.1	0.2	0.2	0.8	3.0	68.3	0.4	0.0	0.3	0.1	6.6	7.7	0.4	7.6	0.0	12.1	0.0	30.0	0.4	2.3	8.7	2.7	0.1	0.3	1.1	3.6	0.6	4.0	0.1	5.7	0.1	6.6	0.2	1.9	0.0	0.0	2.0	0.5	5.3	0.0	0.0	0.3	0.0	2.3	0.7	0.0	0.3	0.2	0.0	0.0	0.0	0.1	0.0	0.1	1.0	3.8	0.0	0.0	0.1	0.0	0.1	0.1	0.8	2.4	0.0	0.0	0.0	0.0	2.0	1.0	0.4	0.1	0.2	0.9	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.6	0.0	3.3	0.0	0.0	0.4	0.0	0.0	1.2	19.0	0.6	0.3	0.2	0.0	0.0	0.1	15.8	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	3.7	1.0	19.1	3.0	68.3	6.6	7.7	30.0	4.0	6.6	5.3	0.0	0.0	0.0	3.6	0.0	0.0	0.1	0.0	1.8	13.2	0.0	0.0	0.7	0.0	0.0	0.0	2.1	0.0	0.0	0.8	0.0	0.0	0.4	0.0	0.2	0.2	224.6	0.0	54.5	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	4.0	10.7	2.0	0.0	0.4	1.6	0.0	0.0	0.0	4.7	0.0	0.5	0.0	3.5	4.9	1.5	0.1	0.0	0.0	0.3	0.2	0.0	0.0	0.9	0.0	1.7	1.0	0.1	0.1	0.2	0.0	0.1	0.0	0.0	0.7	0.0
PHF21B	"BHC80L, FLJ34161, PHF4"	ENSG00000056487	"PHD finger protein 21B"	Q96EK2	22	44881162-45010005	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pituitary gland: 18.9"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 96.6;Cone photoreceptor cells: 22.9;Horizontal cells: 28.6;Late spermatids: 41.9;Oligodendrocyte precursor cells: 29.1;Rod photoreceptor cells: 23.3"	"Cancer enhanced"	"Detected in some"		"glioma: 1.9;prostate cancer: 1.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 11.2;AN3-CA: 10.0;JURKAT: 8.8;SCLC-21H: 8.7;SH-SY5Y: 37.5;U-2 OS: 8.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA053834, HPA074665"	Enhanced		Approved	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"		NA	NA				"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Nucleoplasm, Nucleoli fibrillar center"	Cytosol	"HPA053834: AB_2682276, HPA074665: "	"unprognostic (1.04e-1)"	"unprognostic (7.76e-2)"		"unprognostic (2.00e-1)"	"unprognostic (7.44e-2)"	"unprognostic (1.37e-1)"		"unprognostic (5.45e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.55e-1)"	"unprognostic (3.83e-3)"	"unprognostic (1.86e-3)"	"unprognostic (2.02e-1)"	"unprognostic (9.35e-2)"	"unprognostic (2.27e-1)"	"unprognostic (4.08e-2)"	"unprognostic (1.22e-1)"	0.2	1.2	6.7	0.1	7.9	0.0	0.4	4.8	6.1	9.0	1.5	0.2	0.1	3.2	0.4	0.4	2.5	0.1	0.9	5.1	5.1	2.6	0.0	0.1	0.0	8.5	8.3	4.0	0.5	0.9	18.9	0.0	5.2	5.2	0.0	6.1	0.3	0.5	0.2	0.1	0.2	0.7	4.4	0.1	0.6	5.4	6.8	0.2	2.0	0.3	0.0	0.2	3.2	4.7	0.0	0.0	11.2	10.0	0.0	0.0	0.7	0.0	0.1	0.1	0.1	0.2	0.0	0.0	0.0	0.0	2.0	0.1	2.1	0.0	0.1	0.2	0.7	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.3	0.6	0.0	0.0	8.8	0.0	0.0	0.1	0.9	1.3	0.0	6.7	0.0	0.4	0.0	2.6	0.2	0.0	0.1	8.7	37.5	0.0	0.0	0.1	0.7	0.0	0.0	0.0	1.5	8.5	0.0	0.2	0.4	0.0	5.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	7.9	4.8	6.1	5.1	5.1	8.5	8.3	5.2	4.4	6.8	4.7	0.0	0.0	0.0	96.6	0.0	0.1	0.6	0.0	0.0	14.1	0.0	0.3	2.0	0.0	0.0	0.0	22.9	0.0	0.0	0.0	1.9	0.0	16.2	0.1	3.2	0.4	0.0	0.0	1.0	0.0	0.0	0.8	0.0	0.3	0.0	0.6	0.0	0.0	0.1	28.6	9.1	0.0	0.0	0.0	0.0	41.9	0.6	0.1	0.0	5.6	0.0	5.0	0.0	29.1	9.3	0.1	0.0	1.9	0.0	1.7	0.0	0.0	0.7	23.3	0.0	1.1	0.5	1.2	2.9	0.0	0.0	0.0	0.3	1.9	0.0	0.1
PNMA2	"MA2, RGAG2"	ENSG00000240694	"PNMA family member 2"	Q9UL42	8	26504701-26514092	"Predicted intracellular proteins"		"Tumor antigen"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 88.4;retina: 24.5"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 71.2;Horizontal cells: 30.3;Inhibitory neurons: 92.0;Muller glia cells: 26.9"	"Cancer enhanced"	"Detected in many"		"glioma: 28.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 63.0;hTERT-RPE1: 78.4;JURKAT: 43.3;SH-SY5Y: 44.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001936	Enhanced					NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 65: Brain - Ion transport"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA001936: AB_1079647"	"unprognostic (1.25e-2)"	"unprognostic (1.27e-2)"	"unprognostic (6.39e-2)"	"unprognostic (1.43e-6)"	"unprognostic (1.18e-1)"	"unprognostic (1.37e-1)"	"unprognostic (8.76e-2)"	"prognostic favorable (1.81e-4)"	"unprognostic (4.66e-2)"	"unprognostic (1.34e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.52e-1)"	"unprognostic (9.98e-2)"	"prognostic unfavorable (6.23e-4)"	"unprognostic (5.12e-2)"	"unprognostic (4.58e-5)"	"unprognostic (9.00e-3)"	2.6	10.8	52.2	1.2	55.1	0.4	1.9	1.3	73.4	3.5	0.0	1.4	0.8	0.8	1.0	0.5	2.5	3.9	4.9	55.1	88.4	3.2	0.9	6.8	0.4	29.0	25.7	0.8	3.9	2.7	15.4	0.5	28.7	0.8	0.9	24.5	0.3	0.9	0.5	0.6	1.1	1.9	16.5	0.5	2.8	1.7	67.0	0.2	2.7	0.2	0.3	2.2	0.8	29.2	0.0	11.7	63.0	0.6	12.2	2.6	0.1	3.2	17.2	7.8	2.6	0.5	8.4	0.0	2.3	1.2	19.3	0.2	39.5	0.0	6.0	0.0	7.0	0.0	8.7	0.1	0.9	0.0	0.4	4.2	0.0	33.4	0.2	78.4	37.7	43.3	0.0	0.1	4.9	0.3	19.3	0.1	34.7	0.7	0.1	0.1	12.8	0.0	18.7	4.3	30.7	44.9	0.0	0.1	2.1	4.5	0.2	1.2	18.6	0.8	12.7	16.1	2.6	5.9	4.6	0.1	36.1	0.0	1.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	52.2	55.1	1.3	73.4	55.1	88.4	29.0	25.7	28.7	16.5	67.0	29.2	0.4	3.2	13.0	20.5	0.6	0.0	0.1	0.2	0.0	6.5	0.9	1.1	0.5	0.0	3.7	0.0	2.1	0.0	0.0	0.1	0.0	0.3	5.4	1.0	4.5	1.0	10.8	0.0	71.2	0.0	0.1	3.6	0.0	1.5	1.3	0.0	0.4	0.1	0.1	30.3	92.0	0.5	0.0	1.6	0.8	1.5	11.1	0.1	1.8	12.2	0.0	26.9	0.0	19.1	11.5	2.7	0.0	12.0	0.0	0.0	0.0	5.4	2.9	6.2	0.0	0.2	4.0	0.1	0.9	0.0	0.0	0.0	0.1	0.0	0.2	0.2
PPP1R14C	"CPI17-like, KEPI, NY-BR-81"	ENSG00000198729	"Protein phosphatase 1 regulatory inhibitor subunit 14C"	Q8TAE6	6	150143044-150250392	"Predicted intracellular proteins"		"Protein phosphatase inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 75.5;skeletal muscle: 66.5;skin 1: 97.2;thyroid gland: 58.7"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 280.2;Cardiomyocytes: 79.5;Skeletal myocytes: 80.9;Suprabasal keratinocytes: 336.6"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 53.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HaCaT: 40.7;HBEC3-KT: 86.1;HEK 293: 36.2;hTCEpi: 103.0;hTERT-HME1: 41.1;RPTEC TERT1: 35.5;SK-BR-3: 37.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB044667, HPA047907"	Approved					NA	NA				"Cluster 31: Skin - Epidermis development"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 28: Keratinocytes - Keratinization"			"CAB044667: , HPA047907: "	"unprognostic (1.81e-3)"	"unprognostic (7.65e-2)"	"unprognostic (4.25e-3)"	"unprognostic (6.92e-2)"	"unprognostic (3.96e-3)"	"unprognostic (2.20e-2)"	"unprognostic (3.81e-3)"	"unprognostic (1.55e-1)"	"unprognostic (6.63e-2)"	"unprognostic (5.13e-2)"	"unprognostic (4.50e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.86e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.98e-1)"	"unprognostic (7.49e-3)"	"unprognostic (6.77e-2)"	0.4	0.2	5.1	1.4	6.6	0.2	6.0	5.9	8.0	10.2	6.0	12.5	10.4	1.4	0.9	18.4	16.0	0.1	75.5	7.8	5.0	9.5	0.0	12.3	0.3	5.6	5.4	0.1	0.7	5.1	1.7	3.4	5.6	1.3	8.6	0.6	3.2	0.2	66.5	97.2	2.7	0.9	4.4	0.1	0.8	6.7	5.0	0.5	58.7	8.5	5.8	0.5	22.0	5.0	27.9	0.1	11.7	0.1	0.1	0.6	0.0	3.7	0.0	0.0	0.1	1.3	3.8	0.7	8.0	5.3	1.8	40.7	6.1	86.1	0.0	0.0	36.2	0.3	0.0	0.0	0.0	0.0	1.1	0.0	103.0	0.2	41.1	0.0	0.0	0.5	23.6	0.0	0.0	3.8	0.0	0.0	0.4	0.0	0.2	0.7	0.0	0.0	35.5	1.5	6.2	0.0	0.6	37.7	2.2	0.7	0.2	1.9	0.0	0.1	20.4	32.5	9.5	0.0	0.0	0.0	14.2	16.1	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	6.6	5.9	8.0	7.8	5.0	5.6	5.4	5.6	4.4	5.0	5.0	0.3	19.2	41.1	1.3	0.5	280.2	17.9	19.6	12.0	1.1	6.5	4.3	79.5	0.0	17.1	14.7	0.0	0.1	0.4	24.5	1.9	3.8	0.2	37.9	0.6	3.0	28.2	0.0	28.0	0.2	0.1	6.7	0.0	5.1	1.3	4.1	0.0	0.0	3.0	1.7	13.3	3.1	14.2	0.0	19.7	1.6	0.0	0.6	30.2	2.8	1.1	0.0	0.0	37.2	2.5	12.8	41.5	0.4	0.0	16.6	5.0	38.6	61.5	0.5	0.0	80.9	4.3	0.5	1.8	14.7	336.6	1.9	1.4	0.5	8.7	1.9
PSD	"EFA6, EFA6A, KIAA2011, PSD1, TYL"	ENSG00000059915	"Pleckstrin and Sec7 domain containing"	A5PKW4	10	102402617-102421539	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 233.9;intestine: 261.8"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 50.7;Cone photoreceptor cells: 95.9;Endometrial stromal cells: 47.7;Excitatory neurons: 41.1;Inhibitory neurons: 29.9;Rod photoreceptor cells: 70.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HSkMC: 7.7;MOLT-4: 4.4;SCLC-21H: 7.4;SH-SY5Y: 6.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059237	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 9: Photoreceptor cells - Phototransduction"	Nucleoplasm	"Plasma membrane, Cytosol"	"HPA059237: AB_2683954"	"unprognostic (2.43e-1)"	"unprognostic (1.74e-1)"	"unprognostic (5.62e-3)"	"unprognostic (1.53e-1)"	"unprognostic (3.16e-2)"	"unprognostic (2.90e-2)"	"unprognostic (7.73e-3)"	"unprognostic (1.75e-1)"	"unprognostic (9.59e-2)"	"unprognostic (7.59e-2)"	"unprognostic (2.24e-3)"	"unprognostic (4.71e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.61e-2)"	"unprognostic (8.50e-2)"	"unprognostic (2.24e-2)"	"unprognostic (5.50e-2)"	1.2	9.1	159.5	3.8	151.7	0.7	1.5	7.8	233.9	53.8	0.0	261.8	6.1	78.3	1.4	1.6	46.2	8.9	4.4	220.9	63.9	2.8	2.4	1.2	0.9	23.8	25.4	15.3	5.0	1.5	99.4	0.8	27.3	4.3	3.5	36.8	1.0	1.2	0.4	1.6	41.4	17.7	14.9	1.5	44.2	12.4	70.2	1.4	1.1	0.0	0.4	105.7	14.7	87.6	0.2	0.0	3.0	2.7	1.1	0.6	0.3	0.2	0.0	0.1	0.0	2.1	0.3	0.2	1.8	0.0	0.2	0.2	0.1	0.0	0.0	0.3	0.2	0.1	0.1	0.1	1.6	0.0	0.1	7.7	0.2	0.5	0.1	1.2	0.0	1.0	0.4	0.7	0.0	1.7	4.4	0.2	0.4	0.3	0.0	1.2	0.0	0.1	0.0	0.1	7.4	6.4	0.1	0.1	0.2	0.2	0.5	0.4	0.0	2.2	3.5	0.2	0.0	1.9	0.2	0.1	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	159.5	151.7	7.8	233.9	220.9	63.9	23.8	25.4	27.3	14.9	70.2	87.6	0.7	3.2	0.5	6.8	1.0	0.6	0.3	0.3	0.0	50.7	1.1	0.5	1.5	2.8	1.5	0.0	95.9	0.2	0.6	0.8	1.9	0.2	6.6	4.8	47.7	1.0	18.0	0.0	41.1	1.9	0.2	4.0	2.6	1.8	0.0	0.4	0.0	1.3	0.7	13.5	29.9	0.9	0.0	0.6	0.7	2.7	3.7	0.5	0.0	3.7	0.1	13.2	0.0	9.0	2.4	0.7	1.4	4.1	0.1	0.4	1.3	1.2	0.5	70.8	0.0	2.0	1.1	4.0	3.7	0.7	0.1	0.7	1.9	8.8	1.3	0.1
RBP4		ENSG00000138207	"Retinol binding protein 4"	P02753	10	93591687-93601744	"Cancer-related genes, Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Sensory transduction, Transport, Vision"		"Cancer-related genes, Disease variant, Microphthalmia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	16	"liver: 11920.3"	"Cell type enriched"	"Detected in many"	12	"Hepatocytes: 12711.6"	"Cancer enriched"	"Detected in all"	27	"liver cancer: 3135.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"Hep G2: 1117.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA001641, CAB004555"	Supported				"Secreted to blood"	NA	NA	46100000000	210000000000		"Cluster 62: Liver - Hemostasis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"			"CAB004555: AB_670938, HPA001641: AB_1079795"	"unprognostic (9.42e-3)"	"unprognostic (3.40e-2)"	"unprognostic (1.90e-1)"	"prognostic unfavorable (1.50e-4)"	"unprognostic (2.60e-2)"	"unprognostic (6.69e-4)"	"prognostic favorable (1.74e-8)"	"unprognostic (2.39e-1)"	"unprognostic (5.76e-2)"	"unprognostic (3.26e-2)"	"unprognostic (3.26e-1)"	"unprognostic (3.44e-1)"	"unprognostic (7.14e-3)"	"unprognostic (9.88e-3)"	"unprognostic (2.31e-1)"	"unprognostic (1.03e-1)"	"unprognostic (8.60e-2)"	730.7	32.4	30.2	6.2	34.4	1.1	394.2	12.4	48.1	5.8	12.4	11.2	4.8	2.3	0.9	1.1	2.1	7.5	16.7	32.2	113.0	142.8	11920.3	24.5	0.6	21.5	19.3	4.1	82.4	0.1	519.9	12.4	21.3	8.6	6.7	3.0	13.7	4.6	6.2	16.4	19.2	0.8	14.9	5.5	11.9	4.7	46.2	1.5	7.9	5.3	0.1	19.0	8.8	18.0	0.0	14.7	0.0	0.0	2.9	0.0	0.1	0.3	0.1	2.5	0.4	264.9	0.5	1.5	2.7	0.3	0.2	0.8	0.0	0.0	0.3	0.2	0.2	2.2	1.1	1117.2	0.2	9.2	0.2	18.7	0.5	0.7	0.0	0.0	0.0	0.0	1.4	0.2	1.2	0.0	0.1	7.3	1.3	2.4	121.7	0.4	7.0	0.0	0.0	0.6	0.9	0.2	9.6	0.0	0.0	0.6	0.5	0.8	0.4	0.0	7.8	0.2	0.3	0.9	0.3	3.7	0.0	3.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	30.2	34.4	12.4	48.1	32.2	113.0	21.5	19.3	21.3	14.9	46.2	18.0	9.1	0.0	4.2	0.3	17.2	0.8	0.5	0.0	0.0	0.0	2.1	6.7	0.7	999.4	0.6	23.9	6.2	0.3	0.2	21.9	97.8	7.8	2.8	1.6	3.1	10.8	62.5	152.4	5.8	0.2	22.6	10.5	0.0	22.1	0.0	0.0	158.1	12711.6	17.8	0.0	7.2	40.7	0.0	210.4	3.0	2.4	3.1	7.8	1.8	1.0	0.0	0.8	0.0	1.0	1.1	29.2	28.0	5.7	0.3	2.1	0.8	785.3	0.7	0.5	0.0	7.3	3.8	3.1	13.9	0.0	0.9	1.4	12.3	0.0	1.7	1.4
RIIAD1	"C1orf230, FLJ36032, NCRNA00166"	ENSG00000178796	"Regulatory subunit of type II PKA R-subunit domain containing 1"	A6NNX1	1	151710433-151729805	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"fallopian tube: 24.9;pituitary gland: 34.7;testis: 16.9"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 88.9;Endometrial ciliated cells: 133.2;Enteroendocrine cells: 46.2;Late spermatids: 57.1;Respiratory ciliated cells: 73.9;Spermatocytes: 30.1"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 1.3"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 1.6;SCLC-21H: 1.6;SH-SY5Y: 2.7"	"Low region specificity"	"Detected in all"							HPA045703	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 49: Ciliated cells - Cilium organization"	Cytosol	Nucleoplasm	"HPA045703: AB_10965795"	"unprognostic (8.28e-3)"	"unprognostic (3.42e-1)"	"unprognostic (8.21e-2)"	"prognostic favorable (5.46e-4)"	"unprognostic (1.06e-2)"	"unprognostic (3.09e-1)"	"unprognostic (8.99e-2)"	"unprognostic (3.20e-3)"	"unprognostic (3.95e-1)"	"unprognostic (1.41e-2)"	"unprognostic (3.65e-3)"	"unprognostic (8.50e-2)"	"unprognostic (1.57e-3)"	"unprognostic (2.79e-2)"	"unprognostic (3.06e-2)"		"unprognostic (2.48e-4)"	0.0	1.6	1.9	0.0	2.5	0.0	0.0	3.5	2.5	1.4	0.4	1.0	0.0	0.8	0.1	0.1	24.9	0.0	0.4	2.2	2.5	0.8	0.0	2.4	0.0	1.2	0.9	0.1	0.8	0.1	34.7	0.0	0.5	0.4	0.3	4.8	0.0	0.4	0.1	0.0	0.3	0.3	0.3	0.0	0.9	16.9	2.3	0.0	0.0	0.0	0.0	0.3	0.2	1.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.6	2.7	0.0	0.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	2.5	3.5	2.5	2.2	2.5	1.2	0.9	0.5	0.3	2.3	1.1	0.0	19.2	1.5	0.0	0.0	0.0	0.0	1.0	0.0	8.5	1.1	0.4	15.7	0.0	9.3	5.5	16.7	0.0	0.0	0.1	3.9	3.8	88.9	133.2	0.8	0.4	46.2	0.0	1.8	0.9	0.0	1.2	0.0	1.7	0.0	0.0	0.0	0.0	0.1	0.0	1.1	3.2	0.0	0.0	0.0	57.1	0.6	0.2	3.6	0.0	0.0	0.8	0.0	1.0	0.2	0.4	0.1	1.5	0.0	0.1	0.1	3.0	73.9	3.0	0.0	0.5	1.8	30.1	8.9	0.0	0.0	0.0	0.2	0.1	0.8	0.0
RIPPLY2	"C6orf159, dJ237I15.1"	ENSG00000203877	"Ripply transcriptional repressor 2"	Q5TAB7	6	83853266-83857515	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Developmental protein"	Dwarfism	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 21.2;choroid plexus: 9.6;pituitary gland: 11.2"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 12.0;Excitatory neurons: 10.0;Horizontal cells: 11.8;Inhibitory neurons: 10.5;Oligodendrocyte precursor cells: 13.0;Rod photoreceptor cells: 8.5"	"Cancer enhanced"	"Detected in some"		"glioma: 2.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"GAMG: 19.1;HEL: 6.2;SCLC-21H: 26.0;SH-SY5Y: 17.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047454	Uncertain					NA	NA				"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 62: Horizontal cells - Visual perception"			"HPA047454: AB_2680053"		"unprognostic (2.09e-1)"			"unprognostic (7.43e-2)"	"unprognostic (2.51e-1)"		"unprognostic (1.20e-3)"			"unprognostic (2.69e-3)"	"unprognostic (3.66e-1)"		"unprognostic (6.94e-3)"	"unprognostic (2.30e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.74e-1)"	0.3	1.4	13.8	0.2	14.4	0.0	0.2	17.9	21.2	0.9	9.6	1.3	0.2	0.8	0.0	0.2	0.5	0.3	0.2	14.6	14.6	0.2	0.0	0.1	0.0	13.9	12.7	0.4	1.1	0.0	11.2	0.0	13.8	0.7	0.2	4.2	0.1	0.4	0.3	0.1	0.4	0.3	13.3	0.0	0.7	0.8	13.5	0.0	0.2	0.0	0.0	1.4	0.5	14.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.7	19.1	0.0	0.0	0.0	0.0	0.0	0.0	6.2	0.0	0.0	0.2	0.0	0.0	1.6	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	3.6	0.1	0.0	0.0	1.5	0.0	0.0	1.1	26.0	17.7	1.3	0.1	0.1	0.0	0.1	0.1	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.7	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.8	14.4	17.9	21.2	14.6	14.6	13.9	12.7	13.8	13.3	13.5	14.2	0.2	0.0	0.0	2.0	0.0	0.0	0.4	0.3	1.8	12.0	0.0	0.1	3.5	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.3	1.8	0.0	10.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.8	10.5	0.0	4.1	0.0	0.3	0.5	0.3	0.0	0.0	1.0	0.0	1.4	0.0	13.0	4.6	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.1	8.5	0.0	2.9	1.0	0.8	4.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1
RTBDN	FLJ36353	ENSG00000132026	Retbindin	Q9BSG5	19	12825478-12835428	"Predicted membrane proteins, Predicted secreted proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"retina: 288.0"	"Group enriched"	"Detected in some"	5	"Cone photoreceptor cells: 350.3;Rod photoreceptor cells: 524.0"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"SCLC-21H: 8.3;SH-SY5Y: 5.4;U-266/84: 23.1;U-87 MG: 4.9"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA052511			Approved	"Endoplasmic reticulum"	"Secreted in other tissues"	NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 16: U-266 - Nucleosome"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Endoplasmic reticulum"		"HPA052511: AB_2797243"	"unprognostic (4.55e-4)"	"unprognostic (3.94e-3)"	"unprognostic (2.18e-1)"	"unprognostic (1.54e-4)"	"unprognostic (3.33e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.08e-2)"	"unprognostic (2.45e-2)"	"unprognostic (2.02e-2)"	"unprognostic (3.55e-1)"	"unprognostic (6.48e-2)"	"unprognostic (7.04e-3)"	"unprognostic (7.66e-9)"	"unprognostic (3.55e-2)"	"unprognostic (1.00e-1)"	"unprognostic (7.05e-2)"	"unprognostic (2.24e-2)"	0.0	3.5	5.1	0.1	5.9	0.2	0.0	1.9	10.0	0.0	0.9	1.1	0.4	0.0	0.6	0.0	0.0	0.0	0.0	6.7	2.7	0.0	0.0	0.1	0.0	2.7	1.9	0.0	1.2	0.3	34.3	0.0	5.8	0.0	0.3	288.0	0.0	0.0	0.0	0.1	0.5	0.1	0.9	0.0	1.1	3.3	2.9	8.7	0.0	0.0	0.0	0.0	0.1	3.2	0.9	0.1	0.1	0.6	0.0	0.0	0.7	0.0	0.0	0.4	0.0	0.3	0.0	0.9	0.9	0.0	0.6	0.3	0.3	0.0	0.0	0.0	0.1	0.0	0.4	0.9	0.0	0.1	2.4	0.0	0.0	0.4	0.2	0.0	0.0	0.1	1.3	2.7	0.0	0.1	0.1	0.0	0.9	0.7	1.1	0.7	0.1	1.1	0.1	0.0	8.3	5.4	0.1	0.0	0.4	0.4	2.8	0.7	0.0	0.8	1.0	0.7	0.1	1.2	23.1	4.3	4.9	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	5.1	5.9	1.9	10.0	6.7	2.7	2.7	1.9	5.8	0.9	2.9	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	50.5	0.0	0.0	1.4	0.0	0.1	0.0	350.3	0.0	0.0	0.5	0.0	0.0	0.5	0.1	0.0	1.8	0.0	0.0	2.8	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.6	2.5	0.6	4.1	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	84.4	0.0	1.0	0.7	0.1	0.1	0.0	0.5	0.0	0.7	0.1	0.0	524.0	0.0	0.1	0.0	16.2	5.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0
RUNDC3A	"RAP2IP, RPIP8"	ENSG00000108309	"RUN domain containing 3A"	Q59EK9	17	44308413-44318670	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 208.4;pituitary gland: 98.3"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 55.4;Early spermatids: 24.4;Enteroendocrine cells: 39.0;Excitatory neurons: 46.1;Horizontal cells: 32.0;Inhibitory neurons: 30.4;Late spermatids: 83.4"	"Group enriched"	"Detected in many"	5	"glioma: 8.6;pancreatic cancer: 3.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"SCLC-21H: 62.5;SH-SY5Y: 40.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023548, HPA070733"	Enhanced	Supported	Enhanced	Vesicles		NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 56: Bipolar cells - Visual perception"	Vesicles		"HPA023548: AB_1856069, HPA070733: AB_2732162"	"unprognostic (3.66e-2)"	"unprognostic (3.77e-2)"	"unprognostic (3.50e-3)"	"unprognostic (1.58e-3)"	"unprognostic (3.04e-1)"	"unprognostic (2.02e-1)"	"unprognostic (3.87e-3)"	"unprognostic (2.29e-1)"	"unprognostic (4.63e-2)"	"unprognostic (3.43e-2)"	"unprognostic (1.42e-3)"	"unprognostic (1.34e-1)"	"unprognostic (8.87e-3)"	"unprognostic (1.07e-2)"	"unprognostic (5.17e-2)"	"unprognostic (9.39e-2)"	"unprognostic (1.84e-1)"	0.3	14.3	149.2	0.4	159.5	2.3	0.3	93.0	208.4	0.2	45.6	3.4	1.2	0.5	0.2	0.8	0.2	0.3	1.8	169.4	105.3	1.8	0.2	0.4	0.2	108.0	106.4	0.8	3.8	3.1	98.3	1.5	108.5	0.8	0.6	31.2	0.3	0.3	0.1	7.9	1.3	0.5	79.2	1.6	2.3	15.2	109.4	0.4	1.4	0.3	0.1	0.2	0.7	135.7	0.0	0.4	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.6	4.3	0.0	1.4	0.3	0.0	0.0	0.0	0.1	0.2	0.2	0.0	0.0	0.0	0.0	8.0	0.0	0.2	0.0	0.2	0.0	0.0	0.3	0.0	0.6	0.0	0.9	0.2	0.0	0.5	0.3	0.3	0.1	0.1	1.1	0.3	0.1	62.5	40.3	0.3	0.0	0.3	0.1	0.5	0.8	0.0	0.0	0.2	0.1	0.0	0.0	0.2	0.1	0.2	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	149.2	159.5	93.0	208.4	169.4	105.3	108.0	106.4	108.5	79.2	109.4	135.7	0.1	0.0	0.6	17.3	0.0	0.3	0.3	0.0	0.0	55.4	0.2	0.3	1.1	0.0	0.0	0.0	6.2	0.0	0.0	0.0	3.9	1.3	24.4	0.2	0.3	0.2	39.0	18.7	46.1	3.1	0.0	1.0	0.0	0.2	0.0	0.5	0.4	0.0	0.2	32.0	30.4	0.5	4.1	0.3	0.5	83.4	1.5	0.3	0.0	4.7	0.1	6.5	1.0	16.1	12.5	1.0	1.2	3.4	0.0	0.4	0.0	0.8	0.0	16.8	0.0	0.8	0.5	1.4	1.3	0.0	0.4	0.1	0.1	3.0	0.1	0.3
SEZ6		ENSG00000063015	"Seizure related 6 homolog"	Q53EL9	17	28954901-29006440	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"brain: 54.7;pituitary gland: 15.8;retina: 27.0"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 58.7;Cone photoreceptor cells: 47.9;Excitatory neurons: 15.9;Horizontal cells: 43.7;Inhibitory neurons: 24.6;Rod photoreceptor cells: 18.2"	"Cancer enriched"	"Detected in many"	11	"glioma: 16.6"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"basophil: 1.1;neutrophil: 2.0"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 2.0"	"Cell line enriched"	"Detected in some"	5	"SCLC-21H: 53.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA011777	Enhanced					NA	NA		310000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 6: Brain - Smell perception"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 56: Bipolar cells - Visual perception"			"HPA011777: AB_1856758"	"unprognostic (3.99e-2)"	"unprognostic (1.24e-1)"	"unprognostic (5.75e-3)"	"unprognostic (5.33e-3)"	"unprognostic (1.84e-2)"	"unprognostic (1.76e-3)"	"unprognostic (2.82e-2)"	"unprognostic (2.22e-2)"	"unprognostic (3.07e-1)"	"unprognostic (4.75e-2)"	"unprognostic (1.22e-3)"	"unprognostic (3.15e-3)"	"unprognostic (3.63e-6)"	"unprognostic (1.94e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.45e-1)"	"unprognostic (3.15e-3)"	0.1	0.6	48.4	0.2	54.7	0.4	0.0	50.8	36.3	0.0	5.5	0.9	1.0	0.0	0.3	0.0	0.0	0.0	0.1	36.3	25.0	0.1	0.0	0.1	0.0	20.4	33.0	0.1	0.6	0.0	15.8	0.0	53.5	0.2	0.5	27.0	0.0	0.1	0.2	0.2	0.5	0.1	13.7	0.1	0.5	0.5	25.4	0.0	0.1	0.0	0.0	0.1	0.0	21.1	0.0	0.4	3.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.5	1.1	0.0	0.1	0.1	0.1	0.0	0.0	53.5	9.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.2	0.2	0.0	0.1	1.1	0.2	0.3	0.0	0.1	0.3	0.3	0.1	0.2	0.2	0.1	0.2	0.2	2.0	0.1	0.2	0.3	0.0	0.1	48.4	54.7	50.8	36.3	36.3	25.0	20.4	33.0	53.5	13.7	25.4	21.1	0.4	0.0	0.0	3.3	0.9	0.4	0.7	0.0	0.0	58.7	0.1	0.1	0.6	1.5	0.0	0.0	47.9	0.3	5.0	0.3	0.0	0.2	0.1	0.1	0.2	0.7	7.3	0.0	15.9	0.4	0.3	0.3	0.0	0.2	8.9	1.0	0.4	0.0	0.2	43.7	24.6	0.1	0.0	1.9	1.0	0.4	0.9	1.1	0.0	4.7	5.0	6.1	5.2	3.5	4.7	0.5	0.1	0.0	0.1	0.8	0.7	0.1	0.0	18.2	0.0	0.9	0.3	1.3	1.8	0.0	0.0	0.3	1.4	0.2	0.6	0.2
SEZ6L		ENSG00000100095	"Seizure related 6 homolog like"	Q9BYH1	22	26169462-26383597	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"brain: 60.8"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 222.1;Inhibitory neurons: 137.7;Oligodendrocyte precursor cells: 586.1"	"Group enriched"	"Detected in some"	6	"glioma: 14.6;pancreatic cancer: 3.7"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"intermediate monocyte: 5.9;myeloid DC: 5.7;non-classical monocyte: 5.3"	"Group enriched"	"Detected in many"	58	"dendritic cells: 5.7;monocytes: 5.9"	"Group enriched"	"Detected in some"	6	"SCLC-21H: 39.9;SH-SY5Y: 10.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045135			Approved	Vesicles		NA	NA		6700000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 65: Brain - Ion transport"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Vesicles		"HPA045135: AB_2732518"	"unprognostic (1.01e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.37e-1)"	"unprognostic (4.95e-2)"	"unprognostic (4.49e-2)"	"unprognostic (6.47e-2)"	"unprognostic (4.19e-1)"	"unprognostic (1.09e-2)"	"unprognostic (5.02e-2)"	"unprognostic (7.22e-2)"	"unprognostic (1.39e-3)"	"unprognostic (7.80e-2)"	"unprognostic (2.40e-6)"	"unprognostic (4.52e-2)"	"unprognostic (3.89e-1)"	"unprognostic (2.39e-4)"	"unprognostic (3.18e-1)"	0.1	10.0	25.0	0.5	37.5	0.2	0.0	8.9	50.6	1.1	0.0	0.5	0.4	0.0	0.0	0.0	0.0	0.1	1.3	60.8	52.0	0.0	0.0	0.2	0.0	24.5	23.6	0.0	1.5	0.0	5.8	0.0	19.0	0.2	0.2	4.5	0.2	0.1	0.1	0.3	0.4	0.3	4.0	0.2	1.4	0.3	49.0	0.9	0.1	0.0	0.0	0.1	0.1	24.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	39.9	10.7	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.8	0.0	0.0	5.9	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.0	5.3	0.0	0.0	0.5	25.0	37.5	8.9	50.6	60.8	52.0	24.5	23.6	19.0	4.0	49.0	24.9	0.0	0.0	0.0	21.9	0.0	0.1	0.0	0.0	0.0	3.5	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	1.1	0.2	0.0	0.4	222.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	21.9	137.7	0.0	0.0	0.0	2.1	2.0	0.6	1.5	0.0	10.3	3.5	0.7	0.0	586.1	5.5	0.6	0.0	0.4	0.0	0.1	0.0	0.1	0.0	1.2	0.0	0.2	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0
SIX3	HPE2	ENSG00000138083	"SIX homeobox 3"	O95343	2	44941702-44946071	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Repressor"	"Disease variant, Holoprosencephaly"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	11	"brain: 22.7;choroid plexus: 12.2;parathyroid gland: 9.1;pituitary gland: 27.8;retina: 25.3"	"Group enriched"	"Detected in some"	14	"Bipolar cells: 203.9;Horizontal cells: 185.1;Muller glia cells: 392.3"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 3.3"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in single"		"basophil: 1.5"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	4	"hTERT-RPE1: 68.7;SCLC-21H: 63.1;SH-SY5Y: 25.2"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"basal ganglia: 38.7;hypothalamus: 19.5"	HPA067988			Approved	Nucleoplasm		NA	NA			"Cluster 42: Non-specific - Transcription"	"Cluster 58: Brain - Synaptic function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 5: Muller glia cells - Visual perception"	Nucleoplasm		"HPA067988: AB_2685939"	"unprognostic (1.19e-3)"	"unprognostic (1.05e-2)"	"unprognostic (4.76e-1)"	"unprognostic (1.58e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.76e-2)"		"unprognostic (1.31e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.44e-1)"	"unprognostic (6.82e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.49e-3)"	"unprognostic (3.91e-2)"	"unprognostic (1.76e-1)"		"unprognostic (2.73e-2)"	0.0	0.0	8.3	0.0	22.7	0.0	0.1	0.8	16.4	0.7	12.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	18.2	0.1	0.0	0.0	0.1	0.5	4.5	0.0	0.6	9.1	27.8	0.0	0.5	0.0	0.0	25.3	0.0	0.0	0.5	0.0	0.0	0.0	0.2	0.0	0.0	1.8	10.9	0.0	0.0	0.1	0.0	0.0	0.2	1.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.6	0.0	0.6	0.0	11.7	0.0	0.0	0.6	5.3	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.3	0.0	68.7	0.0	1.4	0.0	0.0	0.0	0.0	0.4	2.7	0.4	0.0	0.3	0.0	0.4	0.0	0.0	0.0	63.1	25.2	0.1	0.0	0.0	0.0	2.1	0.4	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.1	0.3	0.2	0.2	0.3	0.2	0.2	0.1	0.2	0.2	0.2	0.3	0.4	0.4	0.5	0.2	0.3	0.1	8.3	22.7	0.8	16.4	1.8	18.2	0.5	4.5	0.5	0.2	10.9	1.2	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	203.9	1.1	1.3	0.7	0.0	0.0	0.0	4.2	0.0	0.0	0.2	0.0	0.0	11.2	0.0	0.0	0.4	1.8	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	185.1	0.1	0.2	0.0	0.0	0.3	2.7	0.0	0.1	0.0	0.0	0.0	392.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	1.1	0.2	18.3	0.0	0.5	0.4	0.2	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0
SOGA3	"C6orf174, dJ403A15.3"	ENSG00000214338	"SOGA family member 3"	Q5TF21	6	127472794-127519191	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 6.6"	"Group enriched"	"Detected in some"	9	"Excitatory neurons: 78.1;Inhibitory neurons: 57.4;Oligodendrocyte precursor cells: 44.2;Oligodendrocytes: 32.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 9.3;SCLC-21H: 28.9;SH-SY5Y: 16.9"									"HPA035388, HPA035389"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoplasm, Cytosol"		"HPA035388: AB_2674601, HPA035389: AB_10669857"	"unprognostic (1.70e-1)"	"unprognostic (3.56e-2)"	"unprognostic (1.57e-1)"		"unprognostic (2.53e-2)"	"unprognostic (1.19e-1)"		"unprognostic (8.58e-3)"	"unprognostic (8.45e-2)"	"unprognostic (7.31e-4)"	"unprognostic (5.65e-3)"	"unprognostic (1.58e-1)"	"unprognostic (3.33e-2)"	"unprognostic (1.59e-1)"	"unprognostic (3.30e-2)"	"unprognostic (1.72e-1)"	"unprognostic (8.26e-3)"	0.3	0.9	2.3	0.6	2.5	0.0	0.1	2.4	6.6	0.4	0.0	0.3	0.1	0.7	0.0	0.8	0.3	0.7	0.2	2.6	1.7	0.2	0.1	1.0	0.2	3.8	1.2	1.2	0.6	0.0	2.0	0.4	1.9	0.4	0.2	1.2	0.4	0.1	0.1	0.3	0.6	0.1	0.7	0.4	1.3	0.7	3.8	0.0	0.6	0.1	0.0	0.4	0.3	4.4	0.3	4.2	9.3	1.5	0.0	0.8	0.4	0.9	1.1	1.2	2.9	0.3	0.4	0.6	0.3	0.2	7.3	0.0	1.0	0.0	0.7	1.1	0.1	0.8	0.0	0.1	0.0	0.4	0.2	1.5	0.0	4.4	0.0	1.0	0.0	1.5	0.4	0.2	0.7	0.7	6.5	0.0	4.3	0.0	1.0	0.6	2.2	0.0	0.2	0.0	28.9	16.9	0.0	0.0	0.2	1.1	0.0	0.4	0.2	6.8	1.5	0.5	2.2	0.3	0.1	0.1	5.4	1.5	7.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	2.3	2.5	2.4	6.6	2.6	1.7	3.8	1.2	1.9	0.7	3.8	4.4	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.0	78.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	57.4	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.0	0.0	0.0	0.0	44.2	32.9	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	1.9	0.0	0.2	0.1	0.6	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0
SST	SMST	ENSG00000157005	Somatostatin	P61278	3	187668912-187670394	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"		Hormone	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	10	"brain: 449.5;intestine: 386.6;pancreas: 479.4;stomach 1: 418.0"	"Group enriched"	"Detected in some"	4	"Enteroendocrine cells: 1404.1;Intestinal goblet cells: 460.2"	"Cancer enriched"	"Detected in many"	4	"pancreatic cancer: 1039.3"	"Region enhanced"	"Detected in all"		"hypothalamus: 449.5"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 22.4;U-2 OS: 44.7;U-251 MG: 7.6;U-698: 11.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000075, HPA019472, CAB034105"	Enhanced	Supported			"Secreted to blood"	NA	NA				"Cluster 22: Non-specific - Unknown function"	"Cluster 9: U-2 OS - Unknown function"	"Cluster 17: Intestinal endocrine cells - Hormone signaling"			"CAB000075: AB_2688022, CAB034105: AB_2271061, HPA019472: AB_1857360"		"unprognostic (2.44e-1)"	"unprognostic (2.05e-1)"	"prognostic unfavorable (1.93e-5)"	"unprognostic (5.12e-3)"	"unprognostic (1.54e-2)"			"unprognostic (4.69e-1)"	"unprognostic (3.31e-2)"	"unprognostic (8.16e-3)"	"unprognostic (1.63e-1)"	"unprognostic (1.07e-3)"	"unprognostic (8.47e-2)"	"unprognostic (4.19e-1)"	"unprognostic (3.27e-1)"	"unprognostic (1.45e-1)"	5.5	43.0	59.9	4.6	52.1	4.2	0.5	1.3	67.8	0.6	2.5	31.8	386.6	0.7	0.1	1.6	0.4	1.1	1.3	30.6	449.5	6.2	0.3	0.3	1.5	96.9	48.1	2.4	479.4	0.0	9.3	0.1	50.3	1.3	23.8	6.3	0.1	21.6	0.1	8.9	133.3	2.8	137.8	0.2	418.0	0.2	117.2	1.1	1.0	0.0	0.0	7.3	1.8	18.7	0.0	0.0	0.8	0.1	0.0	0.0	0.8	0.1	0.0	0.1	0.0	0.0	0.0	0.0	22.4	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.3	0.5	0.0	0.0	0.0	2.1	0.0	0.2	0.0	0.0	44.7	0.4	7.6	0.0	2.9	11.1	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	59.9	52.1	1.3	67.8	30.6	449.5	96.9	48.1	50.3	137.8	117.2	18.7	0.0	0.0	0.0	9.1	0.5	0.0	0.0	3.3	0.0	0.0	0.2	0.1	0.0	0.0	0.1	5.5	0.0	0.1	0.0	4.3	0.0	0.0	0.3	0.3	0.5	0.1	1404.1	0.0	1.7	0.0	0.2	0.7	0.0	4.2	0.0	0.0	0.0	0.0	0.3	0.0	146.2	460.2	215.7	0.0	0.0	0.1	0.0	0.0	0.0	9.4	3.6	0.0	0.0	3.0	9.1	0.0	0.6	0.0	0.0	0.0	11.9	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.9	13.8	0.2
ST18	"KIAA0535, NZF-3, NZF3, ZC2H2C3, ZC2HC10, ZNF387"	ENSG00000147488	"ST18 C2H2C-type zinc finger transcription factor"	O60284	8	52110839-52460959	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"brain: 82.1"	"Cell type enriched"	"Detected in some"	39	"Oligodendrocytes: 4055.3"	"Cancer enhanced"	"Detected in single"		"pancreatic cancer: 0.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 2.7;SCLC-21H: 9.6;U-87 MG: 1.5"	"Region enhanced"	"Detected in all"		"cerebellum: 40.2"	"Low region specificity"	"Detected in all"			HPA044919	Uncertain					NA	NA				"Cluster 70: Brain - Nervous system development"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"			"HPA044919: AB_10959756"	"unprognostic (3.66e-1)"	"unprognostic (4.34e-2)"	"unprognostic (7.47e-2)"	"unprognostic (2.04e-2)"	"unprognostic (2.78e-1)"	"unprognostic (2.42e-2)"	"unprognostic (1.22e-1)"	"unprognostic (7.11e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.55e-3)"	"unprognostic (2.82e-1)"	"unprognostic (2.53e-5)"	"unprognostic (3.29e-1)"	"unprognostic (1.35e-1)"	"unprognostic (9.34e-2)"	"unprognostic (9.84e-3)"	0.0	0.9	18.4	0.1	48.6	0.0	0.0	44.1	24.1	0.0	1.7	0.1	0.5	0.0	0.0	0.0	0.0	0.2	0.0	18.0	29.0	0.3	0.1	0.1	0.0	47.8	37.4	0.0	1.9	0.0	4.4	0.1	43.5	0.1	0.3	8.5	0.0	0.0	0.0	0.0	0.5	0.0	22.3	0.0	1.5	0.3	35.7	0.1	0.0	0.0	0.1	0.0	0.0	82.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	2.7	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.4	48.6	44.1	24.1	18.0	29.0	47.8	37.4	43.5	22.3	35.7	82.1	0.0	0.0	0.0	4.9	0.6	0.1	0.1	0.0	0.0	101.5	0.0	0.0	1.1	4.3	0.0	0.0	14.6	0.0	0.0	0.1	0.0	0.0	7.4	0.0	0.0	0.2	49.6	1.3	3.4	0.0	0.4	0.2	5.1	0.0	0.0	0.0	0.0	0.2	1.3	1.7	8.5	0.8	10.2	1.6	11.0	1.7	0.0	3.4	0.0	0.0	0.7	2.4	0.0	13.0	4055.3	0.3	0.0	0.0	0.1	0.3	0.1	0.8	0.0	4.5	0.0	0.0	0.1	0.3	0.3	0.0	0.3	0.1	0.1	0.0	0.3	0.0
SYT14	"FLJ34198, sytXIV"	ENSG00000143469	"Synaptotagmin 14"	Q8NB59	1	209900923-210171389	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"			"Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"brain: 7.0;retina: 1.9;testis: 3.2;thyroid gland: 5.0"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 208.7;Inhibitory neurons: 213.9;Oligodendrocyte precursor cells: 152.8;Oligodendrocytes: 197.6"	"Cancer enhanced"	"Detected in some"		"thyroid cancer: 1.9"	"Region enriched"	"Detected in some"	4	"cerebellum: 7.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 9.7;GAMG: 6.7;hTERT-HME1: 4.7;SCLC-21H: 6.5;U-138 MG: 6.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036963			Supported	Vesicles		NA	NA				"Cluster 21: Non-specific - Transcription"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Vesicles		"HPA036963: AB_10670378"	"unprognostic (1.38e-4)"	"unprognostic (8.62e-3)"	"unprognostic (1.93e-1)"	"unprognostic (3.90e-4)"	"unprognostic (1.97e-1)"	"unprognostic (4.43e-5)"		"unprognostic (1.92e-1)"	"unprognostic (1.88e-2)"	"unprognostic (6.85e-2)"	"unprognostic (1.56e-2)"	"unprognostic (3.81e-1)"	"unprognostic (4.85e-3)"	"unprognostic (2.30e-4)"	"unprognostic (1.61e-1)"	"unprognostic (1.76e-1)"	"unprognostic (3.33e-3)"	0.0	0.7	0.4	0.0	0.6	0.0	0.0	7.0	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.2	0.0	0.6	0.0	0.4	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.2	0.2	0.0	5.0	0.0	0.0	0.0	0.0	1.6	2.1	0.0	0.0	0.0	0.0	0.0	0.0	2.5	9.7	2.2	1.2	0.0	0.0	0.0	0.0	0.1	6.7	3.0	0.0	0.0	2.2	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.4	4.7	1.1	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	3.6	0.0	0.3	0.0	0.0	0.0	0.0	1.9	6.5	2.0	0.0	0.0	3.6	0.8	0.0	0.0	1.6	6.4	3.2	0.0	0.9	0.0	0.0	0.0	0.2	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.6	7.0	1.0	0.4	0.3	0.4	0.2	0.4	0.1	0.2	1.6	0.0	0.0	0.0	30.3	0.0	0.0	0.1	0.0	0.0	30.1	0.2	0.0	2.2	0.0	0.0	0.0	27.1	0.0	0.0	0.0	3.9	0.3	17.0	11.6	2.9	0.2	0.0	0.0	208.7	0.6	0.0	0.2	0.0	29.3	0.0	0.9	0.0	0.0	0.0	52.2	213.9	0.0	0.0	0.0	0.0	5.0	0.6	0.2	0.0	3.7	0.0	1.6	0.0	152.8	197.6	0.3	0.0	0.0	0.0	0.7	0.0	0.4	0.0	29.4	0.0	0.9	0.2	6.0	16.8	0.0	0.0	0.0	0.1	0.7	0.0	0.2
TCERG1L	FLJ38950	ENSG00000176769	"Transcription elongation regulator 1 like"	Q5VWI1	10	131092391-131311721	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"brain: 5.0;retina: 6.1;thyroid gland: 14.9"	"Group enriched"	"Detected in some"	5	"Excitatory neurons: 69.9;Horizontal cells: 102.6"	"Cancer enriched"	"Detected in some"	14	"thyroid cancer: 20.3"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 4.3;RPMI-8226: 1.1;SuSa: 1.9;U-2 OS: 1.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA030816			Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 68: Epididymis - Unknown function"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm	Cytosol	"HPA030816: AB_10601721"	"unprognostic (6.61e-2)"	"unprognostic (1.29e-1)"	"unprognostic (8.99e-2)"	"unprognostic (1.45e-2)"	"unprognostic (3.03e-1)"	"unprognostic (6.69e-2)"		"unprognostic (1.62e-1)"	"unprognostic (4.96e-1)"	"unprognostic (9.71e-2)"	"unprognostic (2.02e-1)"	"unprognostic (5.01e-2)"	"unprognostic (1.08e-5)"	"unprognostic (1.28e-1)"	"unprognostic (2.83e-1)"	"unprognostic (2.96e-2)"	"unprognostic (2.03e-1)"	0.0	0.9	1.3	0.0	3.5	0.0	0.1	0.3	5.0	0.1	0.0	0.0	0.0	0.1	0.3	0.4	0.0	0.0	0.0	2.5	1.6	0.2	0.0	0.0	0.0	2.2	1.5	3.0	0.3	0.5	1.3	0.0	0.9	0.6	0.0	6.1	0.0	0.6	0.0	0.5	0.0	0.0	1.5	0.2	0.0	1.6	2.0	0.6	14.9	0.0	0.1	0.1	0.1	2.1	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	3.5	0.3	5.0	2.5	1.6	2.2	1.5	0.9	1.5	2.0	2.1	0.0	0.0	0.0	0.7	0.0	0.6	0.2	0.0	2.2	5.9	0.5	0.1	1.1	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.0	69.9	0.0	0.7	0.9	0.5	0.1	0.0	0.1	0.0	0.0	0.0	102.6	14.5	0.0	0.0	0.0	0.0	0.1	4.7	0.2	10.6	1.0	0.0	0.9	0.0	3.0	2.3	0.1	0.0	4.5	0.0	0.7	0.0	0.0	0.0	4.3	0.0	0.3	0.2	0.4	3.7	2.8	0.6	0.1	0.1	2.5	0.0	0.1
TMEM132D	"KIAA1944, MOLT, PPP1R153"	ENSG00000151952	"Transmembrane protein 132D"	Q14C87	12	129071725-129904025	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	7	"brain: 5.5"	"Group enriched"	"Detected in some"	60	"Excitatory neurons: 448.6;Inhibitory neurons: 523.0;Oligodendrocyte precursor cells: 573.0"	"Cancer enhanced"	"Detected in some"		"thyroid cancer: 0.7"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 2.5;MOLT-4: 4.6;NTERA-2: 1.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA010739	Approved					NA	NA		110000		"Cluster 10: Brain - Neuronal signaling"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA010739: AB_2204753"			"unprognostic (1.69e-1)"		"unprognostic (1.21e-1)"		"unprognostic (1.19e-1)"	"unprognostic (2.07e-2)"	"unprognostic (5.39e-1)"		"unprognostic (1.47e-2)"	"unprognostic (2.89e-1)"	"unprognostic (3.07e-2)"	"unprognostic (1.55e-2)"	"unprognostic (1.55e-1)"	"unprognostic (4.31e-4)"		0.0	0.1	0.9	0.1	5.5	0.1	0.0	0.0	4.9	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.5	1.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.0	0.3	0.1	0.8	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.7	2.3	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.8	0.0	0.0	4.6	0.0	1.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	5.5	0.0	4.9	2.5	1.0	0.0	0.0	0.0	0.0	2.3	1.4	0.0	0.0	0.0	8.5	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.1	0.0	1.8	0.0	448.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	523.0	0.2	0.0	0.0	0.0	1.4	0.0	0.0	0.0	8.4	0.0	0.2	0.0	573.0	7.1	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.1	0.0
TMEM61		ENSG00000143001	"Transmembrane protein 61"	Q8N0U2	1	54980628-54992288	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"kidney: 23.7;parathyroid gland: 13.6;pituitary gland: 47.6;salivary gland: 19.5"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 49.0;Enteroendocrine cells: 48.4;Intestinal goblet cells: 64.4;Ionocytes: 248.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	9	"RPMI-8226: 20.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA030614	Uncertain					NA	NA				"Cluster 17: Adrenal gland - Steroid metabolism"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 27: Mucus-secreting cells - Mucin production"			"HPA030614: AB_10603216"	"unprognostic (7.62e-2)"	"unprognostic (1.67e-3)"	"prognostic favorable (1.07e-4)"	"unprognostic (1.00e-1)"	"unprognostic (6.63e-4)"	"unprognostic (6.15e-2)"	"unprognostic (2.67e-3)"	"unprognostic (1.49e-1)"	"unprognostic (3.05e-1)"	"unprognostic (4.46e-2)"	"unprognostic (1.91e-2)"	"unprognostic (7.24e-2)"	"prognostic favorable (1.78e-7)"	"unprognostic (8.47e-2)"	"unprognostic (2.20e-2)"	"unprognostic (4.01e-2)"	"unprognostic (4.62e-3)"	0.4	6.1	0.7	0.3	0.8	0.0	3.1	3.4	0.7	0.7	1.3	5.8	1.9	0.1	0.1	3.2	2.0	0.3	0.0	0.6	1.8	23.7	0.1	1.0	0.0	3.2	1.2	0.1	3.6	13.6	47.6	0.1	3.2	2.9	1.8	0.2	19.5	4.8	0.2	3.2	4.3	1.0	0.8	0.3	3.6	0.4	1.0	0.3	0.5	0.1	0.0	2.1	1.1	0.4	1.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.2	0.0	0.2	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	20.5	2.0	0.0	0.9	0.0	0.1	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.8	3.4	0.7	0.6	1.8	3.2	1.2	3.2	0.8	1.0	0.4	0.1	0.0	3.1	0.0	0.4	0.9	6.7	8.2	1.8	2.6	10.5	11.6	0.0	0.0	5.7	7.3	2.1	0.1	0.0	4.7	49.0	4.7	0.1	5.5	1.1	0.2	48.4	0.0	0.4	3.4	0.2	0.3	0.0	11.4	0.0	0.1	0.0	0.0	0.1	0.0	0.3	64.4	248.2	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.6	0.5	0.0	0.5	0.1	3.7	7.4	0.7	0.0	3.5	1.3	0.2	10.5	0.9	0.0	1.2	0.8	0.3	1.6	5.3	2.4	0.3	0.1	0.1	2.7	4.1
TRIM46	"FLJ23229, TRIFIC"	ENSG00000163462	"Tripartite motif containing 46"	Q7Z4K8	1	155173787-155184971	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 10.1"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 6.9;Early spermatids: 6.5;Excitatory neurons: 13.1;Inhibitory neurons: 9.7;Late spermatids: 7.5;Oligodendrocytes: 9.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"SH-SY5Y: 9.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055583	Enhanced					NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 65: Brain - Ion transport"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 30: Mammary glandular cells - Lactation"			"HPA055583: AB_2732599"	"unprognostic (1.06e-1)"	"unprognostic (5.07e-2)"	"unprognostic (2.86e-2)"	"prognostic unfavorable (2.61e-7)"	"unprognostic (1.75e-1)"	"unprognostic (7.26e-2)"	"unprognostic (1.59e-2)"	"unprognostic (4.65e-2)"	"unprognostic (4.09e-1)"	"unprognostic (2.88e-2)"	"unprognostic (2.18e-3)"	"unprognostic (1.24e-1)"	"unprognostic (2.29e-12)"	"unprognostic (8.58e-2)"	"unprognostic (2.45e-1)"	"unprognostic (2.70e-1)"	"unprognostic (1.72e-2)"	0.6	0.4	8.3	0.5	9.2	0.3	0.5	8.4	10.1	1.1	4.0	0.8	0.3	3.1	3.3	0.4	2.3	0.4	0.3	9.4	7.6	0.6	0.1	0.5	0.5	7.3	6.3	0.3	0.5	0.1	4.9	0.1	7.5	1.1	0.1	1.1	0.4	0.8	0.1	0.3	0.7	0.9	6.2	1.0	1.0	1.9	7.9	1.1	0.3	0.0	0.2	0.5	0.9	8.8	1.7	2.2	1.5	0.1	0.3	1.3	0.1	1.6	1.7	1.9	2.2	0.0	0.8	0.7	1.1	2.0	0.4	1.8	0.0	0.7	0.6	3.9	0.7	1.3	2.6	0.1	0.8	0.4	4.1	1.4	0.4	2.0	0.7	4.5	2.5	4.1	0.0	3.2	1.0	1.1	2.4	0.2	5.7	0.2	2.3	4.1	0.1	0.8	0.3	0.0	3.9	9.3	0.7	0.5	1.2	0.6	2.8	3.4	3.7	3.8	1.2	0.2	0.8	3.2	1.2	0.7	4.0	0.6	1.1	0.4	0.0	0.0	0.2	0.1	0.2	0.0	0.4	0.4	0.0	0.0	0.1	0.2	0.1	0.1	0.1	0.1	0.7	0.1	8.3	9.2	8.4	10.1	9.4	7.6	7.3	6.3	7.5	6.2	7.9	8.8	0.2	0.0	0.0	1.0	0.3	0.4	0.8	0.2	0.0	6.9	2.9	1.8	1.1	0.0	0.1	0.0	0.0	0.0	0.7	0.1	0.0	0.7	6.5	2.9	0.4	0.7	1.8	0.8	13.1	0.2	0.0	0.8	1.5	3.9	0.0	0.1	0.4	0.0	0.8	0.0	9.7	0.0	0.0	0.0	1.0	7.5	0.3	0.2	0.0	0.0	2.6	0.6	2.1	3.0	9.8	0.0	0.0	0.0	0.5	0.6	0.0	0.0	0.0	1.6	0.0	1.4	0.9	1.3	0.4	0.0	0.0	0.0	1.9	0.0	0.0	0.8
VAT1L	KIAA1576	ENSG00000171724	"Vesicle amine transport 1 like"	Q9HCJ6	16	77788564-77980107	"Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	11	"adrenal gland: 70.1;brain: 186.9;choroid plexus: 232.4;retina: 188.7"	"Group enriched"	"Detected in some"	4	"Horizontal cells: 297.8;Muller glia cells: 106.9"	"Cancer enhanced"	"Detected in many"		"glioma: 7.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 23.1;BJ hTERT+: 68.7;fHDF/TERT166: 38.1;NTERA-2: 79.9;U-87 MG: 82.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044061, CAB046032, HPA061138"	Enhanced		Approved	Cytosol		NA	NA				"Cluster 77: Retina - Visual perception"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 62: Horizontal cells - Visual perception"	Cytosol		"CAB046032: AB_11126308, HPA044061: AB_10959610, HPA061138: "	"unprognostic (1.49e-2)"	"unprognostic (8.74e-3)"	"unprognostic (8.80e-3)"	"unprognostic (3.39e-2)"	"unprognostic (3.62e-2)"	"unprognostic (1.70e-2)"	"unprognostic (2.39e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.86e-1)"	"unprognostic (7.65e-2)"	"unprognostic (8.57e-3)"	"unprognostic (2.46e-1)"	"prognostic unfavorable (3.01e-6)"	"unprognostic (2.50e-2)"	"unprognostic (6.53e-2)"	"unprognostic (1.19e-1)"	"unprognostic (5.96e-2)"	1.8	70.1	30.0	3.3	38.1	0.8	0.5	45.7	24.1	0.7	232.4	3.6	2.3	5.4	6.8	1.7	0.9	4.0	15.2	19.6	186.9	5.3	1.0	0.3	0.4	60.2	53.2	0.3	1.8	0.7	4.5	1.9	84.0	0.3	5.6	188.7	1.4	0.4	0.2	0.1	3.2	2.5	49.9	0.0	1.9	1.9	67.4	0.1	2.4	0.3	2.3	1.4	1.2	37.4	0.0	0.0	23.1	0.0	7.8	0.0	0.0	2.8	68.7	0.9	0.7	0.0	0.0	0.0	0.0	38.1	0.7	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.8	0.0	0.5	0.1	1.7	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.4	79.9	0.0	0.0	1.9	0.0	0.0	0.0	0.0	3.0	3.7	0.0	1.1	0.0	14.1	0.1	18.6	0.1	0.0	8.6	0.0	0.0	0.0	0.0	0.0	82.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	30.0	38.1	45.7	24.1	19.6	186.9	60.2	53.2	84.0	49.9	67.4	37.4	0.1	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	7.0	0.1	0.5	9.2	4.3	0.0	0.0	0.0	0.1	0.0	0.0	1.9	0.2	4.4	0.0	0.2	0.9	3.0	0.0	20.7	0.0	0.0	1.5	0.0	0.1	0.0	0.1	0.4	0.0	0.2	297.8	31.3	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	1.0	0.6	106.9	0.0	44.7	2.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.5	0.0	0.0	0.5	0.0	1.8	0.0	0.0	0.3	0.1	0.1	0.0	0.0